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Regulation of gene expression, through which cells increase or decrease the gene products, is an essential 
part of development, which not only determines the cellular differentiation but also responds to the 
environmental changes. A wide range of gene regulation mechanisms are involved in two major processes, 
from Deoxyribonucleic acid (DNA) to Ribonucleic acid (RNA), and from RNA to protein, also known as 
transcription and translation, respectively. Though the regulation of gene expression is not fully understood, 
this complex process has been characterized to several major steps, which includes epigenetic regulation, 
transcriptional regulation, post-transcriptional regulation and translational regulation. The present study 
covers three main projects related to three of the aforementioned steps of gene regulation. First, we study 
the DNA methylation dynamics in the bovine early embryos. To understand the epigenetic reprogramming 
and regulation in the embryonic development, we characterize the methylation process at the single-base 
level in early embryos. Second, we develop a novel method, called Protein-RNA Association Strength 
(PRAS), to predict the functional targets of RNA-Binding Proteins (RBPs) that play important roles in the 
regulation of gene expression in the post-transcriptional process (Keene 2007). The development of various 
Cross-linking and immunoprecipitation with high-throughput sequencing (CLIP-seq) data makes it possible 
to investigate the transcriptomic binding sites of RBPs (Licatalosi et al. 2008; Hafner et al. 2010; Konig et 
al. 2010; Konig et al. 2012; Cook et al. 2015). We aim to fill the gap between the peak-calling methods and 
the interpretation of RBPs’ biological functions based on CLIP-seq data. Third, we study the regulation of 
c-MYC on the mRNA translation. The oncogenic c-MYC (MYC) transcription factor has broad effects on 
gene expression and cell behavior. We study how MYC affects the global translation of mRNAs and the 
translation start-site usage in the human lymphoma cell line. In sum, we perform data analysis and 
methodology development in these three specific projects related to the regulation of gene expression, 
which will help us better understand the central dogma of biology. 
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CHAPTER 1: INTRODUCTION 
1.1 GENE EXPRESSION REGULATION 
 Gene expression has two major steps: transcription which is from Deoxyribonucleic acid (DNA) to 
Ribonucleic acid (RNA) and translation which is from RNA to protein. A wide range of regulation 
mechanisms are involved in these two major processes, which include epigenetic regulation, transcriptional 
regulation, post-transcriptional regulation and translational regulation. In this thesis, we will cover a project 
related to DNA methylation because DNA methylation provides a stable, heritable, and critical component 
of epigenetic regulation (Goldberg et al. 2007). We will also include one study about RNA binding proteins 
(RBPs). RBPs play critical roles in RNAs’ biogenesis, stability, function, transport and cellular localization 
(Glisovic et al. 2008). We will cover a project related to translational regulation in cancer cell line based 
on the fact that the translational regulation of oncogene expression is implicated in many cancers (Wolfe et 
al. 2014). Taken together, three aforementioned major processes of the gene expression control are studied 
in this thesis, including epigenetic, post-transcriptional and translational regulation. We will describe the 
concept of each of them in details in the following sections. 
 
1.1.1 DNA METHYLATION 
 As mentioned, DNA methylation is an essential component of epigenetic regulation. DNA 
methylation is a process by which methyl groups are added to the DNA molecule. Methylation can change 
the activity of a DNA segment without changing the sequence. In mammals, nearly all DNA methylation 
is cytosine methylation which occurs on CG dinucleotides, with the cytosines on both strands being 
methylated. Regions of the genome that have a high density of CpGs are referred to as CpG islands, and 
DNA methylation of these islands correlates with transcriptional repression (Goll and Bestor 2005). This 
epigenetic process regulates gene transcription for differentiation, gene imprinting, and X-chromosome 
inactivation (Li et al. 1993; Bird 2002; Jaenisch and Bird 2003). Dynamic epigenetic modification of the 
genome occurs during early development of the mammals. The most dramatic genome-wide methylation 
changes occur in primordial germ cells and during preimplantation development (Smallwood et al. 2011; 
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Seisenberger et al. 2012; Smith et al. 2012; Guo et al. 2014; Smith et al. 2014; Gkountela et al. 2015; Guo 
et al. 2015; Gao et al. 2017). In early embryos, this involves the ultimate removal of cytosine methylation 
acquired in the gametes prior to fertilization, a process extensively characterized at the single-base level in 
the mouse, and more recently in humans (Smallwood et al. 2011; Smith et al. 2012; Guo et al. 2014; Smith 
et al. 2014). 
 
1.1.2 RNA BINDING PROTEIN 
 RBPs are proteins that bind to the double or single stranded RNAs and form ribonucleoprotein 
complexes. The RBPs influence the structure and interactions of the RNAs and play critical roles in their 
biogenesis, stability, function, transport and cellular localization (Glisovic et al. 2008). Eukaryotic cells 
encode a large number of RBPs, each of which has unique RNA-binding activity characteristics and roles 
in the regulation of post-transcriptional gene expression (Glisovic et al. 2008). Technologies that 
comprehensively identify the RNA-RBP interactions are developed to discover the mechanisms by which 
RBPs affect RNA processing, such as RNA immunoprecipitation (RIP) and Cross-linking and 
immunoprecipitation (CLIP) (Ule et al. 2003; Gilbert et al. 2004). 
 
1.1.3 RNA TRANSLATION 
 RNA translation is the second step of the central dogma of molecular biology, which encodes the 
protein based on the genetic information in RNA. Protein synthesis is regulated mainly at the translation 
initiation step, which controls the gene expression (Jackson et al. 2010). In this translational control of gene 
expression, a wide range of regulatory elements have been detected, which leads to a greater understanding 
of the translational control mechanisms (Wilkie et al. 2003). In the process of cell growth and development, 
the loss of certain translational regulation can contribute to the initiation and progression of cancer. 
Therefore, altering the protein synthesis machinery is one of the best-known functions of certain tumor 
suppressors and oncogenes (Ruggero and Pandolfi 2003). 
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1.2 RELATED HIGH-THROUGHPUT SEQUENCING TECHNOLOGIES 
 Reduced representation bisulfite sequencing (RRBS) was originally designed to analyze and 
compare genomic methylation patterns as a large-scale approach (Meissner et al. 2005). The principle of 
this technology is that bisulfite converts unmethylated cytosines to uracil (Meissner et al. 2005). By dividing 
the number of reported C (“methylated” reads) by the sum of reported C (“methylated” reads) and T 
(“unmethylated” reads) at the same positions of the reference genome, the methylation levels of each 
sampled cytosine can be estimated. 
 CLIP-seq was originally developed as a method to extract protein-RNA complexes from mouse 
brain with the use of ultraviolet cross-linking and immunoprecipitation (Ule et al. 2003). Improved versions 
of CLIP approaches have been developed and widely used to detect the binding peaks of RBPs at the 
transcriptome scale (Licatalosi et al. 2008; Hafner et al. 2010; Konig et al. 2010; Konig et al. 2012; Cook 
et al. 2015). 
 Ribo-seq, as known as ribosome profiling, is based on the deep sequencing of ribosome-protected 
mRNA fragments, which investigates the status of mRNA translation (Ingolia et al. 2009; Ingolia et al. 
2011). Ribo-seq can be used to monitor the mRNA translation efficiency by correcting with the mRNA 
abundance. In detail, the translational efficiency is calculated from the ratio of ribosome footprint density 
from ribo-seq data to mRNA abundance from mRNA-seq data (Ingolia et al. 2011). 
 RNA-seq, one of the most widely used sequencing technology, was developed to quantify the 
eukaryotic transcriptomes (Cloonan et al. 2008; Lister et al. 2008; Marioni et al. 2008; Morin et al. 2008; 
Mortazavi et al. 2008; Nagalakshmi et al. 2008; Wilhelm et al. 2008; Wang et al. 2009). Since the read 
count bias is commonly presented in the RNA-seq data, normalization is a key step in analyzing it. There 
are mainly two sources of the bias, the sequencing depth and the gene length (Finotello and Di Camillo 
2015). Global scaling, defined as scaling each gene’s read count by the total number of mapped reads, was 
originally used for the purpose of addressing the sequencing depth (Marioni et al. 2008; Mortazavi et al. 
2008; Finotello and Di Camillo 2015). However, recently normalization methods of sequencing depth have 
been developed to correcting the over-representation of high-expressed genes (Anders and Huber 2010; 
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Robinson and Oshlack 2010; Lin et al. 2011; Li et al. 2012; Love et al. 2014). As for the gene length 
normalization, reads or fragments per kilobase of exon (RPK/FPK) are the most widely used methods in 
the data analysis of RNA-seq as well as other sequencing data. 
 
1.3 RESEARCH OBJECTIVES 
 As aforementioned, this thesis includes three major projects that are related to epigenetic, post-
transcriptional, and translational regulation of gene expression. The first project is “DNA methylomes of 
bovine gametes and in vivo produced preimplantation embryos”. In this project, we characterize genome-
scale DNA methylation of bovine sperm and individual in vivo developed oocytes and preimplantation 
embryos by using RRBS data. The findings in this study provide insights into the complex epigenetic 
regulation of gene expression in early embryos. The second project is “PRAS: Predicting functional targets 
of RNA binding proteins based on CLIP-seq peaks”. In this project, we propose the Protein-RNA 
Association Strength (PRAS), which integrates the intensities and positions of the binding peaks of RBPs 
for functional mRNA targets prediction. Leveraging the position information of the binding peaks, PRAS 
is a bridge linking peak-calling methods and the interpretation of RBPs’ biological functions, which 
strengthens the analysis of CLIP-seq data. The third project is “c-MYC regulates mRNA translation 
efficiency and start-site selection in lymphoma”. In this project, we show the oncogenic c-MYC (MYC) 
alter the efficiency and start-site usage of mRNA translation in lymphoma by analyzing the ribo-seq and 
rna-seq data. Our findings in this project provide new insight into the biological activity of MYC and its 
effect on mRNA translation both globally and locally. 
 DNA methylation regulates gene expression in the epigenetic process, RBPs control gene 
expression in the post-transcriptional regulation, and MYC alters gene expression in the protein level in 
lymphoma. The findings in all these three projects provide novel insights into the complex biological 
mechanisms as a step forward to decipher the gene expression control. 
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CHAPTER 2: DNA METHYLOMES OF BOVINE GAMETES AND IN VIVO PRODUCED 
PREIMPLANTATION EMBRYOS 
2.1 INTRODUCTION 
Cytosine methylation is an important epigenetic modification that is largely restricted to CG 
dinucleotides and serves to regulate gene transcription for differentiation, gene imprinting, and X-
chromosome inactivation (Li et al. 1993; Bird 2002; Jaenisch and Bird 2003). The most dramatic genome-
wide methylation changes occur in primordial germ cells and during preimplantation development 
(Smallwood et al. 2011; Seisenberger et al. 2012; Smith et al. 2012; Guo et al. 2014; Smith et al. 2014; 
Gkountela et al. 2015; Guo et al. 2015; Gao et al. 2017). In early embryos, this involves the ultimate removal 
of cytosine methylation acquired in the gametes prior to fertilization, a process extensively characterized at 
the single-base level in the mouse, and more recently in humans (Smallwood et al. 2011; Smith et al. 2012; 
Guo et al. 2014; Smith et al. 2014). Interestingly, the demethylation of the two parental genomes happens 
differently. Immediately after fertilization, the 5-methylcytosine (5mC) in the paternal pronucleus is 
actively converted to 5-hydroxymethylcytosine (5hmC) by the enzyme tet methylcytosine dioxygenase 3 
(TET3) (Inoue and Zhang 2011; Iqbal et al. 2011; Wossidlo et al. 2011). In contrast, the 5mC in the maternal 
pronucleus is largely protected from the actions of TET3 by Stella/Pgc7/Dppa3, which interacts with 
H3K9me2 that is enriched in the maternal pronucleus (Nakamura et al. 2007; Nakamura et al. 2012; 
Bakhtari and Ross 2014). The differentially methylated pronuclei fuse and methylation (5mC and 5hmC) 
levels decrease in a replication dependent manner during cleavage division ultimately reaching a nadir. This 
is followed by large-scale de novo methylation that sets the stage for differentiation (Dean et al. 2001; 
Santos et al. 2002; Petrussa et al. 2016). The gradual demethylation during preimplantation development 
has been observed in humans, mice, and cattle, but the timing of the major wave of genome-wide de novo 
methylation differs (Dean et al. 2001; Smallwood et al. 2011; Smith et al. 2012; Guo et al. 2014; Smith et 
al. 2014).  
To date, the global characterization of the DNA methylation dynamics in embryos of domestic 
species remains at the immunostaining level (Dean et al. 2001; Dobbs et al. 2013; Zhang et al. 2016), with 
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the exception of a few stages of in vitro produced bovine embryos that were analyzed using the 
EmbryoGENE DNA methylation array (Salilew-Wondim et al. 2015). These studies primarily revealed the 
methylation of highly condensed repetitive DNA or the methylation level of sequences represented on the 
array. Although numerous studies have been performed to evaluate the methylation level of selected genes 
and regulatory regions during bovine embryo development (Dobbs et al. 2013; O'Doherty et al. 2015; 
Mattern et al. 2016; Urrego et al. 2017), the complete characterization of DNA methylation at the single-
base level has not been reported. This characterization is critical to understanding the epigenetic 
reprogramming and regulation that occurs during normal, bovine embryonic development in vivo, and to 
providing insight into the epigenetic alterations that occur during in vitro maturation of oocytes and culture 
of embryos after in vitro fertilization. Environmental perturbations experienced during in vitro production 
are expected to influence the epigenetic reprogramming during this critical period, often leading to 
nonrandom epigenetic errors (Li et al. 2005; Fernandez-Gonzalez et al. 2010)  that are linked to imprinting 
diseases in humans (Sutcliffe et al. 2006) and large offspring syndrome in ruminants (Young et al. 1998; 
Chen et al. 2013). 
Reduced representation bisulfite sequencing (RRBS) detects clustered CGs that are mainly located 
in CpG islands (CGI) and are important for gene expression regulation. Here, we performed RRBS of 
bovine sperm, in vivo developed oocytes, and embryos from the 2-cell to the blastocyst stage, obtaining a 
comprehensive single-base resolution map of DNA demethylation dynamics across early bovine 
preimplantation development. This data resource is valuable because it provides the “gold standard” 
reference for embryos produced by assisted reproductive technologies, as well as identifying potential 
regulatory mechanisms of DNA methylation in gametes and during embryo development. Such a rich 
dataset from an economically important agricultural species not only provides evolutionary insights into 
the epigenetics of early development, but also serves as a good model for understanding potential causes of 
human infertility and the epigenetic effects of the assisted reproductive technologies that are designed to 
treat it. 
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2.2 MATERIALS AND METHODS 
2.2.1 RRBS library and pre-processing 
 RRBS libraries were prepared from three replicates of each gamete and embryo stage and 
multiplexed, and sequenced in Illumina Hiseq2500 with 125 bp pair-end reads. In total, we analyzed 30 
samples from 10 stages of development and obtained 165 Gb sequencing data. 
 Multiplexed sequencing reads were first trimmed to remove low-quality bases and adaptor 
sequences using the Trim_galore tool. The clean reads were then aligned to the bisulfite-converted reference 
bovine genome UMD3.1.1 (bosTau8) using Bismark alignment tools (Krueger and Andrews 2011) (version 
0.16.3) with default parameters. Additionally, because the cytosines in a non-CG (CHH and CHG) context 
in the lambda DNA genome are definitely unmethylated, the lambda DNA was rebuilt as an extra reference 
for alignment and the calculation of the bisulfite conversion rate of each sample. Once the alignment was 
completed, the sorted BAM files were generated by Picard toolkit and a pileup file of mapped data was 
created for DNA methylation calculations. 
 
2.2.2 Determination of methylation levels of CpG and non-CpG sites 
 The methylation levels of each sampled cytosine were estimated as the number of reported C 
(“methylated” reads) divided by the sum of reported C (“methylated” reads) and T (“unmethylated” reads) 
at the same positions of the reference genome. Every CpG site with read depth >1 was summed and counted 
in the total CpG coverage of the sample, only the CpG sites with at least fivefold read coverage were used 
to quantify the DNA methylation level of each sample. We then performed the 100-bp tile-based DNA 
methylation calculation algorithm (Smith et al. 2012). First, we binned the reference genome into 
consecutive 100-bp tiles. Then, the number of reported C divided by the sum of reported C and T captured 
in the 100-bp tiles was regarded as the 100-bp-tile averaged DNA methylation level. The DNA methylation 
level for a given sample was the average of the 100-bp tiles, while the DNA methylation level of a stage 
was the arithmetic average value of all biological replicates of that stage. The CpG density for every CpG 
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site was calculated as the total number of all CpGs 50 bp up- and downstream of that CpG site. The CpG 
density for every 100-bp tile was calculated as the averaged CpG number in the tile. The tiles with 
methylation level over or equal to 20% or below 20% were defined as high/intermediate or low methylated 
tiles, respectively. For non-CpG methylation, the same calculation strategy was used. 
 
2.2.3 Characterization of genomic features 
 The annotated retroelements, such as long interspersed nuclear elements (LINEs), short 
interspersed nuclear elements (SINEs), and long terminal repeats (LTRs), and their subfamilies were 
downloaded from the RepeatMasker track of UCSC genome browser. Promoters were defined as regions 
of 1000 bp upstream of transcription start site (TSS) of each gene. Other regions, such as CGIs, exons, and 
introns, were downloaded from UCSC tables with UMD3.1.1 track. The intragenic regions were sequences 
from TSS to transcription end site (TES), while the intergenic regions were defined as the complement of 
intragenic regions in the bovine genome. For each annotated genomic region, the DNA methylation level 
was calculated from the average of all CpG sites in the region with more than fivefold coverage. 
Additionally, when quantifying the DNA methylation level of promoters, only those with at least five CpG 
sites were retained for further analysis. 
 
2.2.4 Identification of dynamically methylated tiles and gamete-specific differentially methylated regions 
 We systematically compared the DNA methylation levels of overlapped 100-bp tiles in each of the 
compared groups or consecutive stages. For example, we regarded 100-bp tiles as gamete-specific 
differentially methylated regions (DMRs) if the methylation levels of one type of gametes (such as the 
sperm) were greater than 75%, while the other type (such as MII oocytes) were less than 25%, with a 
Benjamini-Hochberg false discovery rate (FDR) corrected P ≤ 0.05 from a two-sided Student t test. 
Additionally, if a 100-bp tile had absolute methylation change >40% between the compared groups with an 
FDR-corrected Fisher's exact test of P ≤ 0.05, it was then classified as a changing tile, while the remaining 
 9 
tiles were considered stable. The gene ontology analysis was done for the genes with DMRs using DAVID 
online (https://david.ncifcrf.gov) (Huang da et al. 2009). 
 
2.2.5 Correlation of gene expression and DNA methylation 
 Our previously published gene expression data from bovine in vivo MII oocytes and 
preimplantation embryos, GSE59186 (Jiang et al. 2014) , and the raw data of in vitro MII oocytes, 
GSE52415 (Graf et al. 2014), were pooled and aligned using Tophat2 (Kim et al. 2013) against bovine 
genome UMD3.1.1 (bosTau8) with default settings. Cufflinks (Trapnell et al. 2012) was used for 
quantification of FPKM values with default settings. The log2 of the gene expression levels (FPKM) of 
detectable genes (FPKM >0.1) and the DNA methylation levels of the promoters of each corresponding 
expressed gene were calculated. Finally, Spearman correlation coefficients (r) between gene expression and 
DNA methylation levels of promoters were calculated and plotted in R package. 
  
 
Figure 2.1 Bovine preimplantation embryos undergo genome-wide DNA demethylation. (a) The 
overall methylation levels of bovine gametes and early embryos. The averaged DNA methylation level 
was calculated based on the common 100-base-pair (bp) tiles detected in all stages analyzed. (b) 
Histogram of the fractions of tiles with 0–20%, 20–40%, 40–60%, 60–80%, and 80–100% methylation 
levels across different developmental stages. 
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2.3 RESULTS AND DISCUSSION 
2.3.1 Genome-wide DNA demethylation in bovine preimplantation embryos 
 Using RRBS, we analyzed a total of 30 samples that included bovine sperm and individual in vivo 
matured oocytes and embryos of 10 different developmental stages (n = 3) and obtained 165 Gb of 
sequencing data (Supplementary Table S2.1). The raw FASTQ files and processed methylation calling files 
are available at Gene Expression Omnibus (GEO) (www.ncbi.nlm.nih.gov/geo) under the accession 
number GSE110400. After alignment, we removed three samples with extremely low mapping efficiency 
(Supplementary Table S2.1). The bisulfite conversion efficiency, estimated from spiked Lambda DNA, was 
more than 99% (Supplementary Table S2.1). RRBS provided the expected genomic coverage and 
reproducibility (Supplementary Table S2.1 and Supplementary Figure S2.1a). On average, we captured 
2639,860 CpGs per stage for a total of 10X genome coverage (Supplementary Table S2.1). Captured CpGs 
were broadly spread across each chromosome (Supplementary Figure S2.1b). The overall DNA methylation 
level of each developmental stage was obtained by averaging methylated cytosines in 100-bp tiles of the 
reference genome. Using commonly detected tiles across all stages, the methylation could be divided into 
two distinct profiles (Supplementary Figure S2.1a and Figure 2.1a and b): (1) highly methylated sperm and 
in vivo matured oocytes and (2) cleavage-stage embryos with reduced methylation, the lowest level 
observed at the blastocyst stage (Figure 2.1a and b). These patterns are similar to those found in mice 
(Smallwood et al. 2011; Smith et al. 2012; Wang et al. 2014a) and humans (Guo et al. 2014; Smith et al. 
2014). Two additional profiles are also noteworthy: from the 2-/4-cell to 8-cell stage, and from the 
early/compact morula to the blastocyst stage (Supplementary Figure S2.1a). The demethylation during early 
preimplantation development has been consistently reported in 5mC immunofluorescence-based studies 
(Dean et al. 2001; Fulka et al. 2004; Dobbs et al. 2013; Zhang et al. 2016). However, we did not observe 
the de novo methylation in blastocyst stage embryos that has been observed by immunofluorescence. This 
could be due to several factors, chief among them the analysis of in vivo embryos in this study. In vitro 
production of embryos has long been known to perturb epigenetic modifications (Reis e Silva et al. 2012; 
Canovas et al. 2017). Another potential cause of the discordance could be the difference in resolution 
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between immunofluorescence and RRBS, with the former providing a localized, low-resolution view of 
highly methylated regions in the embryo. Lastly, it could be due to technical attributes inherent to 
immunofluorescence (Salvaing et al. 2015). Indeed, de novo methylation at the blastocyst stage was also 
not observed by high-throughput sequencing analyses (RRBS or MethylC-seq) of mouse (Smallwood et al. 
2011; Wang et al. 2014a) or human embryos (Guo et al. 2014; Okae et al. 2014; Smith et al. 2014). 
 Despite similarities to the patterns observed in mouse and human embryos, distinct features in the 
bovine embryos were observed. Specifically, a dramatic decrease in DNA methylation occurred between 
gametes and the 2-cell stage, with the average DNA methylation level decreasing from 37% in the sperm 
and in vivo MII oocytes to 22% in the 2-cell embryos (Figure 2.1a, Supplementary Figure S2.1c). Of 
interest, a significantly lower methylation level was found in the X chromosome compared to autosomes in 
sperm samples (Supplementary Figure S2.1c). A further and major reduction of DNA methylation to around 
18% occurred as the embryo progressed to the 8-cell stage, coinciding with major embryonic genome 
activation (Misirlioglu et al. 2006; Kues et al. 2008; Graf et al. 2014; Jiang et al. 2014) (EGA; Figure 2.1a, 
Supplementary Figure S2.1c). This is consistent with the loss of methylation over multiple cleavage 
divisions due to the absence of the maintenance DNA methyltransferase 1 (DNMT1) (Kurihara et al. 2008), 
and to major increases in transcription from the embryonic genome (Braude et al. 1988; Hamatani et al. 
2004; Wang et al. 2004; Yan et al. 2013; Graf et al. 2014; Jiang et al. 2014). Subsequently, an even more 
dramatic decrease was seen between the morula and blastocyst stages (16%; Figure 2.1a, Supplementary 
Figure S2.1c). The timing of this second demethylation wave correlated with the differentiation of the 
trophectoderm and inner cell mass, which involves the activation of specific genes, such as POU class 5 
homeobox 1 (POU5F1) and caudal type homeobox 2 (CDX2) (Niwa et al. 2005; Strumpf et al. 2005; 
Sakurai et al. 2016). This is also correlated with the increased DNA methyltransferase 3 alpha (DNMT3A) 
expression in blastocysts (Jiang et al. 2014). In contrast, a moderate increase in DNA methylation was 
found from the 2- to 4-cell, and from 8-cell to early/compact morula, which is consistent with de novo 
methylation due to the elevated DNA methyltransferase 3 beta (DNMT3B) and DNMT3A expression in 4-
cell and 16-cell stage bovine embryos, respectively (Jiang et al. 2014). Also of considerable interest, a 
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significant difference in the methylation level between in vivo and in vitro matured oocytes was found 
(Figure 2.1a and b). In vitro maturation maintained GV oocyte levels of methylation while in vivo 
maturation increased DNA methylation levels; this is consistent with the observation that in vitro 
maturation produces about 75% nuclear maturation, but cytoplasmic maturation is much more incomplete 
(Watson 2007). As a result, in vivo-derived oocytes have a higher developmental potential compared to in 
vitro (Rizos et al. 2002; Smith et al. 2009). These observations provide the underlying mechanism for the 
abnormal gene expression and reduced embryo and fetal development when oocytes are matured in vitro. 
  
 
Figure 2.2 Characteristics of DNA methylation patterns during bovine early embryonic 
development. (a) Averaged DNA methylation levels along the gene bodies and 15 kilobases (kb) up- and 
downstream of the transcription start sites (TSS) and transcription end site (TES), respectively, of all 
reference genes. (b) The averaged DNA methylation level of each developmental stage on annotated 
bovine genome features, including promoters, CGI, exons, and introns. (c) Pearson correlation coefficients 
(r) of DNA methylation levels of promoter regions (purple curve) and the relative expression levels of the 
corresponding genes (red curve). The log2 of the gene expression levels from RNA-seq (reads per kilobase 
per million, RPKM) was calculated and presented. (d and e) The distribution of highly (>20%) and lowly 
(<20%) methylated tiles at each developmental stage against CpG density, respectively. 
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2.3.2 Genome-wide methylation maps and correlation with gene expression 
 As seen in mouse and human embryos (Smith et al. 2012; Guo et al. 2014), a distinct methylation 
pattern was observed in and around all annotated gene bodies, which were progressively more methylated 
than the 15-kb intergenic regions both up- and downstream. Specifically, the TSS (or 0%; Figure 2.2a) was 
associated with a sharp decline in methylation. The methylation then gradually increased in the gene body 
and plateaued until another sharp decline was observed at the TES (or 100%) (Figure 2.2a), which brought 
the DNA methylation close to the level of TSS. These patterns suggest that DNA methylation may be used 
by cells as a unique marker for gene boundaries. Overall, promoter and CGI regions were significantly 
lowly methylated compared to exons and introns (Figure 2.2b) across all stages. This may be necessary 
because early bovine embryos express on average 10,000 genes (Jiang et al. 2014), much higher than most 
differentiated tissues. Using our RNA sequencing (RNA-seq) data of early in vivo developed bovine 
embryos (Graf et al. 2014; Jiang et al. 2014), we found negative correlations between promoter methylation 
and the expression levels of corresponding genes during preimplantation development (Figure 2.2c), 
especially after EGA at the 8-cell stage and later in the blastocyst (r<0.3; Figure 2.2c, Supplementary Table 
S2.2). Because promoters, and to a large extent CGI, hardly changed their methylation levels across 
development, and all the methylation changes were in fact associated with exons and introns (Figure 2.2b), 
we also performed correlation analysis between CGI or exon methylation and the expression levels of 
corresponding genes (data not shown); similar negative correlation patterns were found with CGI or exons 
as in the promoter regions. 
 The bovine gametes and preimplantation embryos exhibited an inverse relationship between CpG 
density and methylation levels (Figure 2.2d and e); regions with high CpG density tended to be 
hypomethylated (<25%) and vice versa (>75%; Figure 2.2d and e), consistent with the patterns observed in 
mouse and human embryos (Smith et al. 2012; Guo et al. 2014). Interestingly, this correlation was more 
visible in gametes, and less so in the 8-cell and blastocyst stage embryos (Supplementary Figure S2.2), 
coinciding with EGA at the 8-cell stage and early lineage specification in blastocysts. 
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Although methylation mainly occurs at CpG sites, non-CpG methylation has been reported in 
oocytes (Tomizawa et al. 2011; Shirane et al. 2013; Guo et al. 2014) and human embryonic stem cells 
(Lister et al. 2009). We also observed reduced but detectable levels of non-CpG methylation in bovine early 
embryos (Supplementary Figure S2.3a). Because RRBS detects methylation mainly in CGIs, the non-CpG 
methylation identified was also located within CGIs. CpG and non-CpG methylation had similar 
enrichment patterns in and around gene bodies (Supplementary Figure S2.3b); this was also observed in 
human oocytes (Guo et al. 2014). Interestingly, extremely low non-CpG methylation was found in the 
sperm, 8-cell, and blastocyst stage embryos (Supplementary Figure S2.3a), all of which had no enrichment 
in gene bodies (Supplementary Figure S2.3b); the low non-CpG methylation was also found in human 
sperm and embryos (Guo et al. 2014). Additionally, there was no correlation between the levels of non-
CpG methylation around gene bodies and expression in bovine gametes and early embryos (r < 0.01; 
Supplementary Figure S2.3c). It has been shown that non-CpG methylation regulates the expression of 
some genes (e.g. pyruvate dehydrogenase kinase 4 (PDK4)) (Barres et al. 2013) while not others (e.g. 
PPARG coactivator 1 alpha (PGC-1α)) (Barres et al. 2009). Since non-CpG methylation is prevalent only 
in specific tissues and cell types, or only in particular regions of the genome, its functional role remains 
unknown (Patil et al. 2014). 
 
2.3.3 Signatures of differential methylation in bovine gametes 
 Although the overall levels of methylation underwent dramatic changes across embryonic stages 
(Figure 2.1a), the actual numbers of tiles with changed DNA methylation between consecutive stages were 
only minor compared to the number of stable ones. The greatest number of changed tiles was found between 
gametes and early cleavage embryos, and between the 4- and 8-cell stage embryos (Figure 2.3a) and 
corresponded to the overall level changes shown in Figure 2.1a. These changing tiles were likely involved 
in the activation of gene expression from the embryonic genome at these stages as we reported previously 
(Jiang et al. 2014). Notably, most regions in the genome showed reduced methylation in the first wave of 
EGA (between MII oocytes and the 2-cell stage) and major wave of EGA (between 4- and 8-cell embryos; 
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Figure 2.3b), likely from replication-dependent dilution and the lack of DNMT1 (Smith and Meissner 
2013). From early morula to blastocyst stage, there was a minor increase in the number of tiles with reduced 
methylation (Figure 2.3a and b), consistent with the increase of methyltransferase expression (DNMT3A, 
B) during this transition (Okano et al. 1999; Smallwood et al. 2011; Smith and Meissner 2013; Jiang et al. 
2014). 
  
 
Figure 2.3 Major transitions in DNA methylation during bovine early development and key features 
of gamete-specific differentially methylated regions (DMRs). (a) The number of common tiles between 
gametes and consecutive stages that changed (black) or were stable (gray) in DNA methylation. (b) The 
number of common tiles between gametes and 2-cell embryos or embryos at consecutive stages of 
development that either had increased (black) or decreased (gray) methylation levels. DNA methylation 
levels in early embryos for tiles hypermethylated (c) and hypomethylated (d) in sperm and in vivo matured 
oocytes. (e) The number of DMRs and the number of corresponding genes between gametes of different 
types. DNA methylation levels of DMRs specific for sperm (f) and in vivo matured oocytes (g) in early 
embryos. Heatmaps of methylation levels (blue to red = low to high) for DMRs specific for sperm (h) and 
in vivo matured oocytes (i) in early embryos. Only DMRs that are significantly different (P < 0.05) 
between sperm and in vivo MII oocytes are presented. (j) Top represented gene ontology (GO) terms 
enriched in genes that had differential methylation between sperm and in vivo matured oocytes. 
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We next examined the similarities in DNA methylation between sperm and oocytes. Sperm and 
MII oocytes showed comparable methylation patterns for most covered tiles, which were either 
hypermethylated (methylation level ≥75%) or hypomethylated (≤25%) in both gametes (Figure 2.3c and d, 
Supplementary Figure S2.4a–d). The hypermethylated regions appeared gradually demethylated across 
cleavage stages, while the hypomethylated regions remained relatively unchanged (Figure 2.3c and d, 
Supplementary Figure S2.4a–d). We further found that regions that were commonly hypermethylated in 
both sperm and oocytes were enriched in LINEs and SINEs as well as introns (Supplementary Table S2.3), 
suggesting that hypermethylated regions in bovine gametes probably mainly serve to repress the activity of 
transposable elements, and play a role in regulating alternative splicing (Sela et al. 2010; Lev Maor et al. 
2015). In contrast, commonly hypomethylated regions were enriched in promoters and CGIs 
(Supplementary Table S2.3), suggesting these regions are important for the dynamic gene activity in 
embryogenesis. A similar phenomenon was seen in human embryos (Guo et al. 2014). 
We also examined significantly (P < 0.05) DMRs between sperm and oocytes. In total, we 
identified 1389 DMRs between sperm and oocytes matured in vivo, which corresponded to 339 genes 
(Figure 2.3 e). Of note, sperm-specific DMRs, which were strongly enriched in LTRs (Figure 2.3 h), rapidly 
lost methylation to the background level by 2-cell stage. Oocyte-specific DMRs, however, were often 
localized to exons and CGIs (Figure 2.3 i) and demethylated gradually across cleavage stages (Figure 2.3 f 
and g, Supplementary Figure S2.4g–j). Consistent with the overall averaged methylation levels (Figure 
2.1a), both oocyte- and sperm-specific DMRs were more methylated than the same DMRs in cleavage and 
blastocyst stage embryos (Figure 2.3 h and i). Gene ontology analysis showed that genes associated with 
gamete-specific DMRs were clearly enriched for active cellular functions, such as regulation of 
transcription, signaling pathway, cell shape, cell fate, and developmental growth (Figure 2.3j). 
Because more developmental failures occur in conceptuses derived from in vitro matured oocytes 
than those matured in vivo (Leibfried-Rutledge et al. 1987; Rizos et al. 2002), we further investigated the 
differential DNA methylation between these two types of oocytes. A total of 52 DMRs (P < 0.05; Figure 
2.3 e, Supplementary Table S2.4), associated with 13 genes, were found (Figure 1.3 e, Supplementary Table 
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S2.4). Interestingly, many of them have not been characterized for their roles in maturation, making them 
good candidates for gene-specific epigenetic modification studies. During in vitro maturation only six tiles, 
corresponding to three genes (Figure 2.3 e), carbonic anhydrase 6 (CA6), caspase recruitment domain 
family member 11 (CARD11), and espin like (ESPNL), changed their methylation from the GV stage. 
 
  
 
Figure 2.4 Dynamics of DNA methylation and expression patterns of transposable elements. DNA 
methylation levels of short interspersed nuclear elements (SINEs; a) long terminal repeats (LTRs; b), and 
long interspersed nuclear elements (LINEs; c). Relative expression levels of SINEs (d), LTRs (e), and 
LINEs (f). 
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2.3.4 Dynamics of DNA methylation and expression patterns of transposable elements 
 SINEs represent the majority of bovine genome repetitive content with LINEs being the second 
most prevalent (Adelson et al. 2009). Since we uncovered high levels of methylation of these sequences in 
the gametes, we were interested in determining the correlation of DNA methylation with the expression of 
SINEs and LINEs across development. Regardless of the sequences, the transposable elements had similar 
DNA methylation dynamics to what was seen for the overall genome methylation, i.e. higher methylation 
in sperm and in vivo matured oocytes, followed by demethylation at the 8-cell stage, reaching a nadir in 
blastocysts (Figure 2.4a–c). Transcription of all transposable elements, however, did not appear to follow 
the changes in DNA methylation except between the 2- and 8-cell stages (Figure 2.4d–f), where there seems 
to be a rough negative correlation of DNA methylation and transcription levels. It is possible that other 
mechanisms, or methylation not revealed by RRBS, are involved. Furthermore, evolutionary age of the 
transposable elements appeared to be correlated with methylation levels. For example, BovB (suggested to 
be old) had the highest methylation levels across all stages compared to other transposable elements 
(Supplementary Figure S2.5a). However, the observation that the evolutionarily younger L1 had a slightly 
higher methylation and transcription levels than L2 in bovine oocytes and early embryos (Supplementary 
Figure S2.5b) may suggest that young transposable elements are not demethylated to the same extent as 
their older counterparts. 
 
2.3.5 DNA methylation dynamics of imprinted genes in bovine gametes and embryos 
 The mechanism of genetic imprinting often involves allele-specific DNA methylation in oocytes 
and sperm (Li and Sasaki 2011). To date, the DNA methylation profiles of bovine imprinted genes have 
not yet been well characterized in bovine gametes and across pre-implantation development, with the 
exception of small nuclear ribonucleoprotein polypeptide N (SNRPN), mesoderm specific transcript 
(MEST), PLAG1 like zinc finger 1 (PLAGL1), paternally expressed 10 (PEG10), insulin like growth factor 
2 receptor (IGF2R), and insulin like growth factor 2 (IGF2) in sperm and oocytes (Gebert et al. 2006; 
O'Doherty et al. 2012), and SNRPN, MEST, PLAGL1, PEG10, IGF2, and imprinted maternally expressed 
 19 
transcript (H19) in day 7 blastocysts (Gebert et al. 2009; O'Doherty et al. 2015). We assessed the 
methylation levels of all 29 genes known to be imprinted in the bovine 
(http://www.geneimprint.com/site/genes-by-species.Bos+taurus) (Tian 2014; Chen et al. 2015; Jiang et al. 
2015). Only 15 were well covered by the captured CpGs using RRBS. Five maternally imprinted genes 
(neuronatin (NNAT), MEST, PLAGL1, PEG10, and SNRPN) had higher DNA methylation in in vivo 
matured oocytes than sperm (Figure 2.5). Conversely, three paternally imprinted genes (H19, maternally 
expressed 3 (MEG3), and tumor-suppressing subchromosomal transferable fragment 4 (TSSC4)) were 
more methylated in the sperm (Figure 2.5). As expected, the methylation levels for these eight imprinted 
genes in cleavage stage embryos were half of the high levels observed in gametes (Figure 2.5). These DMRs 
are good candidates for further study to determine if they are imprinting control elements. Our results not 
only confirmed that a number of bovine imprinted genes contain allele-specific methylated regions 
(Lucifero et al. 2006; O'Doherty et al. 2012), but also provide evidence that the methylation in these regions 
resisted the global demethylation process in early embryonic development as anticipated (Bartolomei 
2009). 
 Interestingly, the methylation patterns of three maternally imprinted genes, retrotransposon Gag 
like 1 (RTL1), sarcoglycan epsilon (SGCE), and IGF2, and four paternally imprinted genes, diacylglycerol 
O-acyltransferase 1 (DGAT1), pleckstrin homology like domain family A member 2 (PHLDA2), IGF2R, 
and GNAS complex locus (GNAS), had the opposite methylation patterns than expected (Figure 2.5). It is 
worth noting that the levels of methylation for SGCE and PHLDA2 were low (Figure 2.5). A previous study 
also reported higher methylation of IGF2 (Gebert et al. 2006) in sperm than in oocytes. In addition, most 
imprinted genes are clustered and controlled by imprint control regions in mice and seven of the clusters 
have been well characterized, including IGF2, IGF2R, and GNAS (Wan and Bartolomei 2008; Barlow and 
Bartolomei 2014). Experiments have also indicated that the DMRs have different effects in these three 
clusters and suggested that knowing the position of the DMR with respect to the imprinted genes in each 
cluster is essential for understanding their exact regulation mechanisms (Barlow and Bartolomei 2014). 
Moreover, the mRNA expression of all these genes, except for GNAS, was extremely low in bovine 
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gametes and early embryos (Jiang et al. 2015); therefore, it is likely that the imprinting regulation of such 
genes involves other epigenetic mechanisms (Bartolomei and Tilghman 1997; Jiang et al. 2015). 
 
 
 
  
 
Figure 2.5 Methylation patterns of imprinted genes in bovine gametes. The DNA methylation levels 
of 15 known paternally and maternally imprinted genes in bovine gametes and early embryos. NA: 
methylation sites were not detected in the regions. 
 
 21 
CHAPTER 3: PRAS: PREDICTING FUNCTIONAL TARGETS OF RNA BINDING PROTEINS 
BASED ON CLIP-SEQ PEAKS 
3.1 INTRODUCTION 
RNA-binding proteins (RBPs) are essential in many post-transcriptional regulatory processes, such 
as alternative splicing, stability, localization and editing (Keene 2007). For example, RBP Quaking plays 
important roles in pre-mRNA splicing and mRNA export (Chenard and Richard 2008); RBP HuR is an 
mRNA stability and splicing regulator (Lebedeva et al. 2011); RBP Ataxin-2 promotes mRNA stability and 
protein expression (Yokoshi et al. 2014). RBPs achieve their functions via binding to RNAs; therefore, it 
is of vital importance to study RNA-protein interaction. Cross-linking and immunoprecipitation followed 
by sequencing (CLIP-seq) approaches have been widely used to detect the binding peaks of RBPs at the 
transcriptome scale (Licatalosi et al. 2008; Hafner et al. 2010; Konig et al. 2010; Konig et al. 2012; Cook 
et al. 2015). Thus, the examination of CLIP-seq peaks informs us of the functional targets of RBPs. 
Existing computational approaches for analyzing CLIP-seq data focus on detecting RBP binding 
peaks (Althammer et al. 2011; Corcoran et al. 2011; Uren et al. 2012; Lovci et al. 2013; Chen et al. 2014; 
Moore et al. 2014; Wang et al. 2014b; Wang et al. 2014c; Comoglio et al. 2015; Shah et al. 2017) or 
differential RBP binding peaks between two different conditions (Althammer et al. 2011; Uren et al. 2012; 
Erhard et al. 2013; Wang et al. 2014c). Computational methods for predicting the functional consequence 
of RBP binding peaks are less well-established (Mukherjee et al. 2011; Modic et al. 2013; Rot et al. 2017). 
Some studies suggest that the binding preferences of RBPs are associated with their specific functions. For 
example, HuR binding preferentially occurs close to the 3’ splicing site, which is consistent with its known 
function on alternative splicing (Lebedeva et al. 2011); Ataxin-2, an mRNA stability regulator, has a 
tendency to bind close to the polyadenylation site (Yokoshi et al. 2014). A recent study revealed that RBP 
TDP-43 regulates poly(A) site usage in a position-dependent way (Rot et al. 2017).  
In this paper, we develop a new approach named Protein-RNA Association Strength (PRAS), which 
incorporates the intensity and positional information of CLIP-seq peaks to quantitate the association 
between an RBP and its targets. We apply PRAS to study two CUGBP ELAV-like family proteins, CELF4 
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and CELF1 with both CLIP and perturbation RNA-seq data available. CELF4 (also known as Brunol4) is 
expressed as an mRNA regulator in the central nervous system across species (Meins et al. 2002; Yang et 
al. 2007). The deficiency of CELF4 is associated with a complex neurobehavioral disorder including 
seizures and autism-like features in human (Halgren et al. 2012; Barone et al. 2017) and in mice (Wagnon 
et al. 2011). iCLIP studies revealed that CELF4 preferentially binds, almost exclusively in 3’ untranslated 
regions (UTRs), to mRNAs encoding many important neurological functions, (Wagnon et al. 2012). CELF1 
is implicated in myotonic dystrophy (Timchenko et al. 1996).  CELF1 is highly expressed in early 
embryonic stages and are then down-regulated dramatically in skeletal muscle and the heart during 
development (Ladd et al. 2005; Kalsotra et al. 2008). CELF1 has been reported to promote transcript 
deadenylation and the abnormal up-regulation of its protein level could contribute to the myotonic 
dystrophy pathology (Moraes et al. 2006; Wang et al. 2015). A more refined understanding of the functional 
targets of CELF RBPs is essential for understanding the impact of CELF in development and diseases, and 
may provide clues as to the mechanisms by which CELF impacts mRNA function. In addition, to 
demonstrate the robustness of PRAS, we examined its performance of detecting the functional targets in a 
large-scale collection of eCLIP data of RBPs in the integrated encyclopedia of DNA elements in the human 
genome (ENCODE). By applying PRAS to the eCLIP peaks of the RNA decay regulators, we demonstrate 
that PRAS outperforms other existing methods and also provide deeper understanding in the post-
transcriptional regulation of these RBPs.  
 
3.2 DESIGN AND IMPLEMENTATION 
3.2.1 The framework of PRAS 
The basis of PRAS is to score a potential functional target of an RBP based on both the intensities 
and positions of its binding sites. Our pipeline of calculating PRAS is shown in Figure 3.1. First, given a 
CLIP-seq dataset, the significant cross-linking sites that are within a small interval of each other (default: 
20 nt) are merged as RBP binding peaks. If the called binding peaks are provided, we will use them directly. 
Second, if a reference position is provided by the user based on known knowledge of the function of the 
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RBP, PRAS will use it directly; if no reference position is given, PRAS will set it based on the RBP’s 
binding preference, e.g., the distal end of the 3’ UTR of the transcript (aka polyadenylation site). Finally, 
each transcript is scored as the sum of the intensities of the binding peaks weighted by the distances between 
the mid points of the binding peaks and the preselected reference position. All mRNAs are then ranked by 
the PRAS scores and can be tested for associations with functions. 
  
 
Figure 3.1 Flowchart of the PRAS pipeline. There are mainly three steps in calculating the PRAS scores. 
First, we merge the significant cross-linking sites as the binding peaks. Then, we use user-provided or 
automatically selected reference position and score each transcript based on both the intensities and the 
positions of the binding peaks. Finally, we rank the targets by PRAS and test RBP functions by 
independent datasets. The details of the PRAS calculation are described in the following section. 
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3.2.2 PRAS score calculation 
As described in Fig 1, the PRAS score is based on the weighted sum of the intensities of the binding 
given detected CLIP-seq peaks. In the study that analyzed the interaction between DNA and proteins with 
ChIP-seq datasets, the exponential decay function was used to characterize the decreasing effects of a 
transcription factor binding peak on its targets with increasing distances (Ouyang et al. 2009). Therefore, 
we here construct the score to describe the regulatory effect of an RBP on its targets in a similar way. 
Specifically, we define the PRAS score for an mRNA as: 𝑆 = ∑ 𝑟%𝑒'()/(+% ,                                                    (1) 
where 𝑟% is the intensity (CLIP-seq read counts) of the ith peak cluster of the RBP, 𝑑% is the distance (number 
of nucleotides) between the reference position and the ith peak cluster, and 𝑑- is a constant. For both CELF4 
and CELF1 in mouse, we set the reference position as the distal 3’ UTR and the constant 𝑑- = 1000	nt. 
Note that 𝑑- = 1000	nt is the default setting, but not a hard-set option in PRAS. For the RNA decay 
regulators in human, we set the constant 𝑑- = 500	nt. The details of 𝑑- estimation for RBPs in mouse and 
human are described in the Results and Discussions sections. 
 
3.2.3 PRAS implementation 
PRAS is implemented in Python (version 2.7.14 or above) and R (version 3.3.2 or above) scripts 
and has minimum requirements for the inputs. To reformat the annotation file, PRAS takes use of 
gtfToGenePred, a toolkit from the UCSC Genome Browser (Kent et al. 2002). PRAS also uses BEDTools 
(Quinlan and Hall 2010) to efficiently obtain the overlapping between the binding sites and the annotation 
regions. The annotation file should be the Gene Transfer Format (GTF) format and the peak file (no special 
requirement for the peak caller) should be the Browser Extensible Data (BED) format as the required input 
files, which are both the standard file formats. Details of usage can be found on the instruction page of our 
website: https://github.com/ouyang-lab/PRAS. 
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3.3 RESULTS AND DISCUSSIONS 
3.3.1 PRAS score is a strong predictor of PCR-validated mRNA targets of CELF4 
CELF4 is expressed in excitatory neurons of the adult mouse brain, from which iCLIP data are 
available (Yang et al. 2007; Wagnon et al. 2011; Wagnon et al. 2012). We collected the significant cross-
linking sites detected by iCount (http://icount.fri.uni-lj.si) with false discovery rate (FDR) less than or equal 
to 0.05. We conducted a metagene analysis involving all 9,193 mRNAs that are bound by CELF4 and noted 
an enrichment of iCLIP reads at the distal (3’ end) versus proximal (5’ end) 3’ UTR (Supplementary Figure 
S2.1). This preference suggests a potentially functional role of CELF4 binding close to the polyadenylation 
site. 
We calculated the PRAS scores for CELF4 binding mRNAs with the polyadenylation site as the 
reference position, which gives the binding sites closer to the polyadenylation site higher weights. We 
estimated the decay parameter 𝑑- in Equation (1) based on the strength of the peak intensity decay shown 
in Supplementary Figure 3.1. In detail, we defined the weighting formula as 𝑤 = 𝑒'(/(+  according to 
Equation (1). The highest average peak density, 0.843, appears at 63 nt to the 3’ end of 3’ UTR and the 
average peak density at 1000 nt upstream to the 3’ end of the 3’ UTR is 0.285 (Supplementary Figure S3.1). 
We calculated 𝑤 as the ratio between the average peak intensity at the 1000 nt upstream to the 3’ UTR and 
that of the 3' end of the 3’ UTR, which is 0.285/0.843 = 0.339. By plugging d = 937 nt (which is 1000 nt – 
63 nt) and w = 0.339 into the weighting formula, we obtained the estimation of 866 nt for 𝑑-, which is 
approximately the default of 1000 nt. For comparison, we applied the expressRNA procedure of Rot et al.  
  
 
Figure 3.2 Diagram of three ranking methods. 
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(Rot et al. 2017), which sums the number of reads in CLIP peaks within 200 nt upstream and downstream 
flanking the polyadenylation sites (Figure 3.2). We also applied the procedure in Wang et al (Wang et al. 
2015), which calculated the score as the number of significant CLIP peaks per kilobase (noted as PPK; 
Figure 3.2). Each of the three measurements ranks CELF4 binding mRNAs from high to low scores. 
We then evaluated the performance of PRAS, expressRNA, and PPK on a list of known functional 
targets previously validated by qPCR in wild-type and Celf4 null mouse brain, totaling 23 mRNAs (Wagnon 
et al. 2012). To investigate the ability of the three measurements to identify CELF4 functional targets, we 
performed receiver operating characteristic (ROC) analysis. We extracted the log fold change (LFC) of the 
qPCR values in Celf4 null mouse brain over wild-type. The mRNAs with positive and negative LFCs were 
labelled as CELF4-degraded and CELF4-stabilized genes, respectively. The area under the curve (AUC) of 
the ROC curve was used to measure the prediction performance of the methods. We found that PRAS 
perfectly distinguished the PCR-validated CELF4-degraded and CELF4-stabilized genes (AUC=1), 
outperforming expressRNA (AUC=0.867) and PPK (AUC=0.7) (Figure 3.3a). This result suggests that 
given CLIP peaks, PRAS has greater ability to capture the functional targets of CELF4 compared to 
expressRNA and PPK. In addition, we examined the quantitative relationship between the PRAS scores 
and the qPCR LFCs of these known targets. A negative Pearson’s correlation coefficient (-0.60) was 
obtained, suggesting that the more negative qPCR LFC a target has, the larger the PRAS score is (Figure 
3.3b). The advantage of PRAS over expressRNA and PPK can be attributed to two factors. First, PRAS 
utilizes the binding bias of CELF4 towards the distal 3’ UTRs of its validated targets (Figure 3.3c). 
expressRNA partially utilizes this bias by considering the 200 nt flanking region around the polyadenylation 
site, whereas PPK does not consider the binding bias. Second, unlike expressRNA which only considers a 
fixed flanking region, PRAS considers all binding peaks, which decreases loss of important RBP binding 
sites. The analysis of the validated targets of CELF4 suggests the importance of binding near the 
polyadenylation sites as a potential factor on how it regulates gene expression. By applying different decay 
parameter 𝑑- to PRAS, we found that PRAS obtained equally good performance over a reasonable range 
of 𝑑-s (Supplementary Figure S3.2A and B). A 𝑑- that falls out of certain range will decrease the 
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performance of PRAS (Supplementary Figure S3A and B), because a too small 𝑑- can filter out the majority 
of iCLIP signals and a too large 𝑑- approximates the uniform weighting. The stable performance of PRAS 
with 𝑑- chosen around 1000nt shows the robustness of PRAS (Supplementary Figure S3). 
 
  
 
Figure 3.3. The qPCR-validated targets of CELF4. (a) The plot of ROC curves for PRAS, expressRNA, 
and PPK in the qPCR validated targets. The ROC analysis was done on the three methods’ scores and the 
expression change. The corresponding ROC curves for PRAS, expressRNA, and PPK are indicated by red 
solid, blue dashed, and green dotted lines, respectively. The AUC of the corresponding ROC curves are 
listed at the bottom of the plot. (b) The scatter plot of the PRAS score against the qPCR log fold change 
(LFC). The X-axis represents the log2 fold change in qPCR from the wild-type to Celf4 null mouse brain. 
The Y-axis shows the log10 of PRAS score. Each black dot represents a validated target by the qPCR. 
The regression line is highlighted in blue color. The Pearson’s correlation coefficient is indicated by the 
red text on the plot. (C) The heatmap of binding signals of the qPCR-validated targets. The X-axis 
represents the distance to the 3’end of the 3’ UTR, and the Y-axis shows the genes in the validated list. 
The color shows the log2 of read counts of CELF4 iCLIP-seq within its significant peaks, where the 
warmer the color is the stronger the binding is. The black bars in each row shows the distance from the 5’ 
end of the 3’ UTR to the 3’ end of the 3’ UTR, which indicates the length of each 3’ UTR. 
a b
c
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3.3.2 PRAS score correlates with global mRNA change induced by CELF RBPs 
To assess the ability of PRAS to detect RBP functional targets in the entire transcriptome, we 
extracted the top 500 genes ranked by permutation test p-values in the differential expression test between 
the wild-type and Celf4 null mouse brain based on existing microarray datasets (Wagnon et al. 2012). We 
calculated the LFC for gene expression in Celf4 null over wild-type mouse brain. The mRNAs have lower 
abundance (LFC < 0) in Celf4 null genotype are more likely to be CELF4-stabilized targets, while the 
mRNAs with higher abundance (LFC > 0) in Celf4 null brain were more likely to be CELF4-degraded 
targets. We sought to assess the ability of PRAS on capturing CELF4-stabilized vs. CELF4-degraded 
targets. Specifically, we first set a sequence of cutoffs as the quantiles (from 0.05 to 0.95 with step size as 
0.05) of the distribution of the absolute value of the expression LFCs. Second, for each cutoff, we extracted 
a subset of genes whose absolute expression LFC is larger or equal to the cutoff. Finally, for each subset of 
potential CELF4 targets, we calculated the Spearman’s correlation coefficient between the expression LFCs 
and the PRAS scores, in which the magnitude and sign of the correlation reflect the association between 
the two. For comparison, we also applied the same correlation analysis to expressRNA and PPK ranking 
scores. Line-charts of the Spearman’s correlation coefficient of the three methods are shown in Figure 2.4a. 
We observed that the more stringent the expression LFC cutoff for the gene subset was set, the stronger the 
negative correlation between the PRAS score and the expression LFC was obtained, which suggests that 
PRAS is more powerful in capturing more reliable CELF4-stabilized targets. In addition, the expressRNA 
score is less correlated with the expression LFC, and the direction of the correlation between the PPK score 
and the expression LFC flips at different cutoffs. The results suggest that PRAS has greater ability to select 
the regulated mRNA targets compared to expressRNA and PPK. 
We also extracted the top 500 genes ranked by their adjusted p-values in the differential expression 
test between the wild-type and Celf1 over-expression in mouse muscle based on published RNA-seq 
datasets (Wang et al. 2015).  In this dataset, mRNAs that have higher abundance upon Celf1 over-expression 
(LFC > 0) are more likely to be CELF1-stabilized targets while those that have lower abundance upon Celf1 
over-expression (LFC < 0) were more likely to be CELF1-degraded targets. We evaluated the performance 
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of the three aforementioned methods using the same analysis as with CELF4. We used the 3’ end of the 3’ 
UTR as the reference site in PRAS to rank the mRNA targets based on the reported binding preference of 
CELF1 (Wang et al. 2015). PRAS has a stronger negative correlation with the expression LFC compared 
to expressRNA and PPK for each subset of the potential CELF1 targets (Figure 3.4b). These results suggest 
that PRAS is more powerful in capturing the reliable CELF1-degraded targets, consistent with the main 
regulatory function of CELF1 (Wang et al. 2015).  
  
 
Figure 3.4 Correlation analysis between PRAS score and gene expression change. (a) The line-chart 
of Spearman’s correlation coefficient between the gene score and the gene expression LFC in the Celf4-
regulated list. The lower X-axis represents the different cutoffs applied to extract the subset of genes, the 
upper X-axis represents the number of genes corresponding to the applied cutoffs, and the Y-axis shows 
the value of Spearman’s correlation coefficient. The corresponding curves for PRAS, expressRNA, and 
PPK are indicated by red, blue, and green lines, respectively. Each dot in the plot is for one subset of genes 
selected based on the absolute LFC cutoff. (b) Similar line-chart to A, but for the Celf1-regulated list. 
These two line-charts show that the higher ranked targets by PRAS have higher enrichment in the regulated 
lists comparing to the top ranked lists of expressRNA and PPK. 
a
b
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Next, we used different reference sites in PRAS for scoring functional targets of CELF4 and CELF1 
in order to examine the effect of the reference site selection. We scored the targets of CELF4 using the 5’ 
end of the 3’UTR as the reference site in PRAS (PRAS 5’) and did a similar correlation analysis as above. 
We observed that the PRAS 5’ score is also negatively correlated with the expression LFC and the 
magnitude of correlation improves with increasingly stringent cutoffs (Supplementary Figure S3.3A). 
However, the magnitude of the correlation is not as high as that of PRAS with the 3’ end of 3’ UTR as the 
reference site (PRAS 3’) (Figure 3.4a). We also similarly analyzed the targets of CELF1 using PRAS 5’. 
Again, the PRAS 3’ has stronger negative correlation with the expression LFC than PRAS 5’ for the more 
reliable CELF1 targets (Supplementary Figure S3.3B). The results indicate that known biological 
knowledge can aid in reference site selection in PRAS for identifying the functional targets of the CELF 
proteins. The results also suggest that both the CELF4 and CELF1 proteins may regulate mRNAs via the 
distal 3’ UTRs while having opposite effects on their targets. Indeed, this is plausible because CELF 
proteins play various roles in both co-transcriptional and post-transcriptional RNA regulation, as well as 
translation inhibition in different cellular contexts (Mukhopadhyay et al. 2003; Subramaniam et al. 2008; 
Dasgupta and Ladd 2012).  
To examine the difference of taking the raw or the normalized read density of the CLIP peaks as 
the input of PRAS, we then used the Celf4 null iCLIP-seq as the negative control for the wild-type CELF4 
iCLIP to score the functional targets of CELF4 with the 3’ end of the 3’UTR as the reference site. 
Specifically, we replaced the iCLIP-seq read counts 𝑟% in Equation (1) by the enrichment ratio 𝑟% × 𝑙𝑜𝑔9(;)<)) 
as suggested by Van Nostrand et al (Van Nostrand et al. 2018). We noted the PRAS score using the raw 
read intensity and the enrichment ratio of peaks as PRAS-raw and PRAS-norm, respectively. By applying 
the correlation analysis as above, we found that PRAS-norm has achieved stronger negative correlation 
with the expression LFC than PRAS-raw (Supplementary Figure S3.4). This improvement of performance 
indicates the important role of the negative control in reducing the noise, which is consistent with the results 
in (Van Nostrand et al. 2016). Even though PRAS-raw cannot achieve as good performance as PRAS-norm, 
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the difference in the performance between them is small (Supplementary Figure S3.4), which indicates that 
PRAS can handle the situation where the negative control of CLIP-seq is not available, such as the CELF1 
data in our study. 
3.3.3 PRAS identified targets are strongly enriched in functional categories 
To further compare the functional relevance of the targets identified by PRAS, expressRNA and 
PPK, we performed gene ontology (GO) analysis on the top 500 mRNA targets of CELF4 ranked by each 
score (Figure 3.5a-c), which is similar to the analysis shown in Wagnon et al (Wagnon et al. 2012). There 
is much greater enrichment (5 to 40 orders based on p-values) of the categories related to suspected CELF4 
function in the targets identified by PRAS than those identified by expressRNA and PPK. For example, in 
the class of “Biological Process”, most of the top 10 significant categories for PRAS top-ranked targets are 
related to neuron or synaptic functions and ion transport, consistent with prior studies on CELF4 (Wagnon 
et al. 2012). These results suggest that PRAS captures CELF4 functional targets more precisely than the 
other methods being compared.  
  
 
Figure 3.5 GO analysis of the top ranked targets in different methods and top differentially 
expressed genes. (a) “Biological Process” GO analysis line-chart. X-axis represents the GO term and Y-
axis is the -log10(p-value) from the David GO analysis tool (https://david.ncifcrf.gov/) for the top 500 
targets ranked by each method. PRAS is highlighted by red solid line, expressRNA is highlighted by blue 
dashed line, and PPK is highlighted by green dotted line. (b) Similar plot to A but for “Cell Compartment” 
GO analysis. (c) Similar plot to A but for “Molecular Function” GO analysis. 
a b c
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3.3.4 Functional targets are identified in a large-scale PRAS application to human RBPs 
To demonstrate that PRAS has the potential for wide adoption, we further applied PRAS to the 
eCLIP data (Van Nostrand et al. 2016) in two human cell lines, K562 and HepG2, from the ENCODE 
consortium (Consortium 2012). Specifically, we selected the RBPs that are related to the RNA decay 
function (Van Nostrand et al. 2018) because this function can be clearly quantified at gene level in the 
differential expression (DE) analysis between the RBP knockdown and the wild-type RNA-seq samples. 
We collected the DE analysis results by DESeq (Love et al. 2014) from ENCODE and obtained 37 distinct 
RBPs, which include 28 and 32 RBPs in HepG2 and K562 cell line, respectively. We then applied PRAS 
to the eCLIP data using the enrichment ratio over the control sample described above as the peak intensities. 
In the parameter settings in PRAS, we selected the reference site for each RBP from 4 candidates: 
transcription start site, translation initiation site, translation termination site, and transcription end site, 
based on eCLIP peak intensity distribution along the transcript. Supplementary Figure S3.5 presents four 
example RBPs assigned with 4 different reference sites. To simplify the analysis, we applied 𝑑- = 500	𝑛𝑡 
to all the selected RBPs according to the distribution (Supplementary Figure S3.6) of the estimated decay 
parameters as described previously. This general selection of 𝑑- may not achieve the best performance of 
PRAS but is likely to be comparable with the best 𝑑- selection as discussed in the CELF4 data. After 
obtaining the PRAS scores, we did the correlation analysis of the DE (adjusted p-value <= 0.05) genes for 
each RBP. We found PRAS scores achieved significantly stronger correlation with the LFC in gene 
expression in comparison to expressRNA and PPK, with p-value equal to 3.8e-9 and 4.4e-4, respectively 
(Figure 3.6a). We then separated the RBPs by their reference site usage and found that the translation 
termination site and the transcription end site, both of which are related to the 3’ UTR, constitute the 
majority of the RNA decay regulators’ reference sites (Figure 3.6b). It suggests the essential association 
between the 3’ UTR of transcripts and the regulation of their fates by RBPs. In addition, we found that the 
correlation can reflect important biological functions of RBPs. For example, the 5’ poly(A) site 
(transcription end site) is used as the reference site for DDX6 in the HepG2 cell line (Supplementary Figure 
S3.5 C) and the PRAS score is negatively correlated with the LFC of DDX6’s target gene expression (Figure 
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3.6b), which indicates that DDX6 may stabilize its targets via binding near to the poly(A) site. Interestingly, 
DDX6 is known to be an important regulator in mRNA decapping and degradation (Fenger-Gron et al. 
2005; Hu et al. 2015), which supports our claim that PRAS has the ability to identify the biologically 
functional targets of the RBP regulators. All these results demonstrate that PRAS has the potential for wide 
adoption in RBP functional targets identification. 
  
 
Figure 3.6 PRAS applied to RNA decay related RBPs. (a) The CDF curve of the absolute correlation 
coefficient between the gene score and LFC in gene expression. X-axis represents the absolute value of 
the Spearman’s correlation coefficient between the gene score and LFC in gene expression (KO over wild-
type). PRAS, expressRNA, and PPK is highlighted by red, blue and green line, respectively. The p-value 
of one-sided Mann-Whitney test is listed on the figure. (b) Heatmap of the Spearman’s correlation 
coefficient. The Spearman’s correlation coefficient between the gene score and LFC in gene expression 
for PRAS, expressRNA and PPK are listed from the left to the right. The values of the correlation 
coefficient are indicated by the color, where red and blue color indicates the positive correlation and the 
negative correlation, respectively. RBPs are grouped by their reference site usage and their ID and cell 
lines are listed at the right side. 
 
a
b
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3.3.5 Discussions on biological insights from the use of PRAS 
In this study, we developed PRAS, a position dependent scoring method for identifying and 
prioritizing RBP functional targets. Weighting the proximity of RBP binding sites to a given reference 
position exponentially and combining the strengths of the binding signals, we obtained the PRAS scores 
and the ranking of all the mRNAs that have reliable binding sites of the RBP. We applied this approach to 
the iCLIP dataset of a neuronal disease-related RBP, CELF4 and to the CLIP dataset of a DM disease-
related RBP, CELF1 – both belonging to the CELF family of RBP. We report a much stronger association 
between CELF4 and its targets at the distal 3’ UTRs compared to internal 3’ UTR positions. We also 
demonstrate that PRAS performs much better in predicting the mRNA targets stabilized by CELF4, 
compared to the other existing methods such as expressRNA and PPK. We further observe that PRAS 
performs much better at predicting the mRNA targets degraded by CELF1. These results not only suggest 
the importance of incorporating the positional information of the binding sites into target identification, but 
also suggest the important roles of the distal 3’ UTRs in CELF protein regulated mRNAs. 
The binding preferences of RBPs have been noticed in previous studies (Lebedeva et al. 2011; Wagnon et 
al. 2012). However, the link between positional biases of RBP binding sites and their functional 
consequences has not been well established. PRAS reveals that the distal end of 3’ UTR binding is 
predictive of CELF4-stabilized targets. The distal end bias of CELF4-stabilized targets suggests possible 
molecular mechanism(s) by which CELF4 regulates its mRNAs. It has been reported that poly(A) tails 
enhance the stability of mRNAs (Subtelny et al. 2014). The proximity between poly(A) tails and the distal 
3’ UTRs suggests possible connections with poly(A) tail functions, such as mRNA stability, 
polyadenylation itself or promotion of translational reinitiation – possibilities to be explored in future 
experimental studies. CELF1 is known to recruit cytoplasmic deadenylases (Vlasova-St Louis et al. 2013) 
and the extent of mRNA degradation is positively correlated to CELF1’s binding magnitude to the 3’ UTRs 
(Wang et al. 2015). Based on the finding in the previous study (Wang et al. 2015) that CELF1 binding is 
enriched in the 3’ end of the 3’ UTR, we further found that this binding bias shows strong predictive ability 
to CELF1-degraded targets (Figure 3.3 b).  We also demonstrated the potential of PRAS in the large-scale 
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applications by showing the better performance of PRAS than other methods in identifying the targets of 
RNA decay related RBPs from ENCODE (Consortium 2012). These results again strengthen the 
relationship between the regulatory functions of the RBPs and their binding positions. 
 
3.4 AVAILABILITY AND FUTURE DIRECTIONS 
PRAS is implemented in Python and R and is freely available at https://github.com/ouyang-
lab/PRAS. PRAS can be applied widely to identify the functional targets of any RBPs with CLIP-seq peaks. 
For RBPs with a known post-transcriptional function, the functional targets may be identified with a 
corresponding reference position that is related to that function (e.g. splicing sites for alternative splicing). 
PRAS can also be combined with other types of information, such as sequence motifs, conservation, and 
perturbation data to predict RBP functional targets using integrative approaches such as (Zhang et al. 2010). 
In addition, future versions of PRAS can be extended to study the co-regulations of multiple RBPs by being 
applied to a set of interested RBPs simultaneously and evaluating the importance of different reference sites 
on the targets. 
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CHAPTER 4: C-MYC REGULATES MRNA TRANSLATION EFFICIENCY AND START-SITE 
SELECTION IN LYMPHOMA 
4.1 INTRODUCTION 
MYC, known as an oncogenic transcription factor, has been reported to play an essential role in 
both normal and malignant cell bionomy. Existing studies focus on the transcriptional effect of MYC, and 
it is known that consensus E-boxes are the immediate targets of MYC to achieve selective effects (Land et 
al. 1983; Blackwood and Eisenman 1991). In the recent studies of MYC biology, the augmentation function 
of the expression of active genes has been reported, so MYC has also been described as a “global amplifier” 
(Lin et al. 2012; Nie et al. 2012). More recently, the interactions between MYC and coactivators or 
inhibitors are reported to contribute to the transcriptional effects, which refines the understanding of its 
global-amplification function (Ouyang et al. 2009; Walz et al. 2014; Kress et al. 2015). Besides the role of 
transcription factor, it has also been reported that MYC is associated with the control of mRNA translation. 
However, these reported effects of MYC are secondary, such as changes in the expression of ribosomal 
proteins and translation factors, or mRNA capping (Schlosser et al. 2003; Arabi et al. 2005; Grandori et al. 
2005; Cole and Cowling 2009; van Riggelen et al. 2010). 
The translational regulation in cancer have been reported in metabolism, migration, and metastasis 
(Topisirovic and Sonenberg 2011; Hsieh et al. 2012; Pourdehnad et al. 2013; Elkon et al. 2015; Truitt et al. 
2015; Lindqvist et al. 2018), which have been largely attributed to activation of the mTOR/4EBP1/eIF4E 
signaling axis (Lin et al. 2008; Hardie et al. 2012; Bhat et al. 2015; Morita et al. 2017; Saxton and Sabatini 
2017). In the present study, we show the effect of MYC on global mRNA translation efficiency (TE), and 
on translation start-site usage using harringtonine to arrest the initiating ribosomes. 
 
4.2 RESULTS 
4.2.1 MYC has global and specific effects on mRNA translation in lymphoma cells 
We performed transcriptome-scale ribosome profiling to identify precisely which mRNAs are 
affected translationally by MYC. This method isolates changes in translation from changes in transcription 
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by relating ribosome-protected fragment (RF) reads to total mRNA levels (Pajic et al. 2000; Ingolia et al. 
2009; Wolfe et al. 2014). We performed the study in triplicates on P493-6 human B lymphoma cells that 
express MYC in a doxycycline-sensitive manner and compared high- and low-MYC states at a 24-h time 
point. Important quality-control data are shown in Supplementary Figure S4.1 a–c, and described in the 
figure legend. For most transcripts, the change in translation as indicated by ribosome coverage (RF reads) 
was proportional to the change in mRNA abundance (r = 0.41; Figure 4.1, indicated by the gray diagonal 
line). However, using a strict statistical cutoff at q < 0.01, we identified mRNAs whose translation was 
disproportionally affected by MYC. Specifically, the TE was up-regulated in the high-MYC state for 882 
mRNAs (TE up) and decreased (TE down) for 315 mRNAs (Figure 4.1 and Supplementary Figure S4.1 d, 
marked in red and blue, respectively). 
 
  
 
Figure 4.1 Change in total mRNA levels versus change in RF reads in the presence or absence of MYC 
in P493-6 cells. The linear function indicates proportional changes in both: genes with a significantly (q 
< 0.01) disproportional increase in TE (TE up, red) or decrease (TE down, blue). Ribosome footprinting 
was performed in three biological replicates for each group. 
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4.2.2 MYC changes translation initiation sites (TISs) and open reading frames (ORFs) 
Next, we wanted to explore to what extent MYC affects translation start sites and potentially the 
integrity of ORFs. We experimentally mapped TISs in the presence and absence of MYC by performing 
ribosome profiling in the presence of harringtonine. Briefly, harringtonine arrests the initiating ribosomes, 
and this is readily detectable as an RNase I–protected sequence peak overlaying the actual start site (Fresno 
et al. 1977; Robert et al. 2009). We performed the experiment in triplicates, removed one outlier sample 
from further analyses (Supplementary Figure S4.2 a), and discarded irrelevant reads. A metagene analysis 
(for positions −2 to +90) confirmed a robust harringtonine-induced arrest (Figure 4.2 a and b). Briefly, we 
determined the peptidyl (P-site) offset for different read lengths by aligning the ribosome-protected reads 
to the annotated AUG start codons (Supplementary Figure S4.2 b). On average the P-site offset was 12 
nucleotides, and we used this number to identify alternate TISs (ATISs; Supplementary Figure S4.2 c). In 
both conditions, most transcripts initiated from a single TIS (Supplementary Figure S4.2 d and e). We used 
the ORF-RATER algorithm to identify all consensus and variant TIS in each condition; the program 
identifies TISs based on a ribosome-protected RNA sequence peak and the presence of a potential start site 
NUG, where N represent A/T/G/C. Briefly, we grouped annotated RNA isoforms that share a genomic 
position on the same strand into “transcript families.” We used an ORF-RATER score > 0.8 as a significant 
cutoff and used only these ORFs for further analyses (Fields et al. 2015). 
We noticed a surprising variation in actual versus predicted TISs. The predicted TIS was the first 
consensus AUG start codon and gave rise to a functional ORF and protein; the ATIS reflects actual 
ribosome accumulation upon initiation arrest with harringtonine. Overall, we detected ∼23% of ATISs in 
both MYC conditions (Figure 4.2 c). Generally, in the presence of MYC, we detected a significant (P = 4.3 
× 10−08) increase in the usage of 5′ upstream ATISs that corresponded to upstream ORFs (uORFs) and 
new ORFs that overlapped with the annotated start sites (Figure 4.2 d and Supplementary Figure S4.2 f). 
This change was also detected by increased 80S ribosome coverage across 5′ upstream mRNA sequences 
(Supplementary Figure S4.2 g). Conversely, as a general rule with some exceptions, we saw a significant 
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(P = 1.2 × 10−03) shift to an ATIS downstream (3′) from the annotated site in the absence of MYC; the 
latter is expected to give rise to N-terminal truncations (Figure 4.2 d and Supplementary Figure S4.2 f). 
This change was also reflected in the start codon choice, and alternate ORFs typically initiated from near 
cognate CUG, GUG, or UUG codons instead of the annotated AUG codon (P < 0.05; Supplementary Figure 
S4.2 h and i). Hence, high- and low-MYC conditions lead to surprising usage of up- and downstream ATIS, 
respectively. 
  
 
Figure 4.2 MYC affects TIS choice. (a and b) Metagene analysis of TIS detection in the presence and 
absence of MYC under harringtonine (Harr)-induced translation arrest (2 µg/ml; 2 min). Ribosome 
densities were averaged after aligning the gene density profile at the TIS to obtain the mean normalized 
read density. n = 3 biological replicates in each group. (c) Annotated and ATIS in all ORFs detected in 
MYC ON and OFF samples. n = 3 biological replicates in each group. (d) Annotated and alternate ORFs 
detected in the presence/absence of MYC; significance by Fisher’s exact test. n = 3 biological replicates 
in each group. 
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Figure 4.3 High-MYC conditions favor upstream translation initiation. (a) The peak height ratio of 
RF reads across the annotated TIS versus the uORF TIS indicates preferential uORF initiation for most 
uORF-containing genes in the MYC ON condition. n = 3 biological replicates in each group. (b) GO 
identifies categories of genes with MYC-activated uORFs. n = 3 biological replicates in each group. (c) 
List of genes harboring uORFs in the MYC ON state by KEGG category. n = 3 biological replicates in 
each group. (d) RF distribution with and without harringtonine for XPOT indicates uORF usage in the 
MYC ON state; black and red arrows indicate the predicted (TIS) and ATIS, respectively. n = 3 biological 
replicates in each group. (e) MYC-induced 5’ extended ORFs ranked by the number of additional N-
terminal amino acids. n = 3 biological replicates in each group. (f) RF read distribution across the SRSF1 
transcript in high and low MYC indicates variable ATIS usage. Harr indicates harringtonine arrest. Black 
arrows indicate predicted TIS and ATIS, respectively. Exons shown as black squares. n = 3 biological 
replicates in each group. 
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4.2.3 Variant ORFs result in abnormal proteins 
 First, we examined ATIS usage in high-MYC conditions. Read count ratios from the annotated TIS 
and ATIS indicated that, when both were present in a transcript, the ATISs were preferred (80%) over the 
annotated TIS (20%; Figure 4.3 a). We do not know the biological relevance of these extended variant 
ORFs (ntotal = 233, nspecific = 157; Figure 4.2 d, Supplementary Figure S4.2 f). However, GO analysis 
indicated a significant enrichment for genes that were also MYC and E2F transcriptional targets (Figure 
4.3 b and c). Recent studies indicate that under stress conditions uORFs enhance the translation of the 
downstream ORF (Vattem and Wek 2004; Sendoel et al. 2017). Consistently, we observed that the presence 
of a uORF is linked to increased or unchanged, but never to reduced, TE (Supplementary Figure S4.2 j). 
One example is the XPOT gene encoding exportin-T, a nuclear exporter of aminoacylated transfer RNAs, 
which gains a prominent uORF in high-MYC states (Arts et al. 1998)(Figure 4.3 d). In other instances, 
MYC activation leads to 5′ extended ORFs that encode N-terminally extended proteins. This group includes 
many RNA-binding proteins including SRSF family members (Figure 4.3 e). The SRSF1 transcript showed 
loss of initiation from the annotated TIS and relative increases of usage of both 5′ and 3′ ATIS (Figure 4.3 
f). The variable use of ATISs likely affected production of the functional protein. 
  
 
Figure 4.4 Low-MYC expression favors downstream start sites that lead to functional N-terminal 
truncations. (a) Genes ranked by the distance of ATIS from TIS resulting in truncated ORFs. n = 3 
biological replicates in each group. (b) RF distribution across the eIF4B transcript under harringtonine 
(Harr) treatment in MYC ON and OFF states. Arrows indicate the predicted TIS and the ATIS, the 
zoomed-in region on the right illustrates differential usage of the ATIS in MYC ON and OFF states. n = 
3 biological replicates in each group. 
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The absence of MYC favored initiation from an ATIS downstream (3′), and this would cause N-
terminal truncations (Figure 4.2 d and Supplementary Figure S4.2 f). Generally, the ATIS in low-MYC 
conditions were typically located between 3 and 5,038 nucleotides downstream from the annotated AUG, 
they were typically CUG or GUG codons, and in low-MYC states, the ATIS was preferred (70%) over the 
annotated TIS (30%; Supplementary Figure S4.3, a–c). Some examples of N-terminally truncating start 
sites include mTOR and translation regulators such as LARP1, eIF4B, eIF3M, eIF2B5, eIF4E2, and eIF4B 
(Figure 4.4 a). The ORF-RATER identified the new ATIS based on an RF peak, and the presence of a 
potential start site; for example, eIF4B acquired a new ATIS in exon 11 resulting in a truncated protein that 
loses all relevant RNA-binding domains (Shahbazian et al. 2010)(Figure 4.4 b). 
 
4.3 MATERIALS AND METHODS 
4.3.1 ORF analysis using harringtonine data 
 We predicted the annotated and alternative ORFs for MYC ON and OFF samples using ORF-
RATER (Fields et al. 2015). Both untreated and harringtonine-treated samples were used to perform the 
prediction analysis, in which harringtonine ON samples contributed to the prediction of the TIS, and 
harringtonine OFF samples contributed to the prediction of both the TIS and translation termination sites. 
We extracted the reliable uORFs, truncated ORFs, extension ORFs, start-overlap ORFs, internal ORFs, 
new ORFs, and annotated ORFs using 0.8 as the score cutoff suggested by Fields et al. (Fields et al. 2015). 
MYC ON– and MYC OFF–specific ORFs are those ORFs that were detected only in MYC ON or MYC 
OFF samples, respectively. 
 
4.3.2 Alternative and annotated initiation site peak ratio analysis 
For genes with ATISs, we compared the relative translation level of the alternative ORF and its 
corresponding annotated ORF using the peak ratio of the translation start site. We extracted the sum of the 
footprint read counts in the region of −30 nt to +30 nt relative to the ATIS and annotated TIS in the 
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harringtonine-treated samples. We calculated the peak ratio of an alternative ORF as the reads ratio of the 
ATIS to the annotated TIS. 
 
4.3.3 Metagene analysis 
For each gene, we calculated the mean ribosome footprint density across the positions on the 
longest transcript of a gene with ≥64 footprint read counts. We normalized the positional footprint density 
of each gene by the average footprint density. Then we scaled both the 5′UTRs and CDSs of genes to an 
equal number of windows and calculated the averaged signals across all genes as the metagene profile. We 
plotted the final metagene profile by averaging the metagene profiles across replicates. 
 
4.3.4 CDS ribosome pause site analysis 
Similarly, we used the normalized footprint density of the longest transcript of each gene that has 
≥64 ribosome footprint read counts for the CDS ribosome pause-site analysis. We defined the normalized 
codon density as the sum of the normalized footprint density of the nucleotides at positions −1, 0, and +1 
relative to the first nucleotide of that codon. We considered a codon as a ribosome pause if the codon density 
was ≥150. This cutoff was decided by the 0.1% quantile of the normalized codon density distribution along 
the CDSs. CDS ribosome pause sites were excluded if they are within 5 codons to the TIS or the translation 
stop sites. We aligned the metagene profile of the flanking region around the ribosome pause sites and 
plotted the averaged signals. 
 
4.3.5 CDS ribosome pause-site motif analysis 
We extracted the peptide sequences of the flanking region around the pause sites as the positive 
sequence set for the motif analysis. We choose the 5-peptide upstream and downstream flanking region to 
the pause site, which is 11 peptides in total including the pause-site peptide. We generated a set of random 
regions with the same size outside the flanking regions of the pause sites and extracted the peptide 
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sequences of these random regions as the negative sequence set. Then, we did the motif analysis based on 
the positive and negative sequence sets. 
 
4.4 DISCUSSION 
Our findings provide new insight into the biological activity of MYC and its effect on mRNA 
translation. We mapped the global and gene-selective effects of MYC activation on mRNA translation. 
MYC has surprising and profound effects on the choice of translation start sites in mammalian cells. We 
found that TIS choice affects the integrity of ORFs and, therefore, the production of functional proteins. In 
general, we observed that MYC activation shifts TIS upstream from the annotated site, whereas low-MYC 
states correspond to the opposite effect. The 5′ shift activates uORFs and produces overlapping and 5′ 
extended ORFs, whose biological activities are not yet known. The 5′ truncation seen in low-MYC 
conditions deletes important functional domains and may also affect protein stability. For example, the 
eIF4B translation initiation factor loses all of its RNA-binding domains and is unlikely to retain activity. 
Immediately relevant to lymphoma therapy is the effect on the CD19 cell surface receptor. Under low-
MYC conditions, we observed predominant usage of a downstream TIS that results in loss of all receptor 
ectodomains. This change impairs detection by antibodies against the CD19 N-terminus, and it also protects 
lymphoma cells from attack by CD19-directed CAR-T cells. Clinically, loss of surface CD19 has been 
linked to resistance to CAR-T cell therapy for lymphoma although the molecular mechanism has not been 
defined (Sotillo et al. 2015; Perna and Sadelain 2016). Our results indicate that alternate translation start-
site choice can lead to the expression of abnormal cell surface receptors. Altogether, we found 
physiologically relevant effects of MYC levels on the efficiency of mRNA translation and the integrity of 
ORFs and proteins. 
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CHAPTER 5: CONCLUSIONS  
 DNA methylation is an important epigenetic modification that undergoes dynamic changes in 
mammalian embryogenesis, during which both parental genomes are reprogrammed. Despite the many 
immunostaining studies that have assessed global methylation, the gene-specific DNA methylation patterns 
in bovine preimplantation embryos are unknown. Using reduced representation bisulfite sequencing, we 
determined genome-scale DNA methylation of bovine sperm and individual in vivo developed oocytes and 
preimplantation embryos. We show that (1) the major wave of genome-wide demethylation was completed 
by the 8-cell stage; (2) promoter methylation was significantly and inversely correlated with gene 
expression at the 8-cell and blastocyst stages; (3) sperm and oocytes have numerous differentially 
methylated regions (DMRs)—DMRs specific for sperm were strongly enriched in long terminal repeats 
and rapidly lost methylation in embryos; while the oocyte-specific DMRs were more frequently localized 
in exons and CpG islands (CGIs) and demethylated gradually across cleavage stages; (4) DMRs were also 
found between in vivo and in vitro matured oocytes; and (5) differential methylation between bovine 
gametes was confirmed in some but not all known imprinted genes. Our data provide insights into the 
complex epigenetic reprogramming of bovine early embryos, which serve as an important model for human 
preimplantation development. 
 RNA-protein interaction plays important roles in post-transcriptional regulation. Recent 
advancements in cross-linking and immunoprecipitation followed by sequencing (CLIP-seq) technologies 
make it possible to detect the binding peaks of a given RNA binding protein (RBP) at transcriptome scale. 
However, it is still challenging to predict the functional consequences of RBP binding peaks. In this study, 
we propose the Protein-RNA Association Strength (PRAS), which integrates the intensities and positions 
of the binding peaks of RBPs for functional mRNA targets prediction. We illustrate the superiority of PRAS 
over existing approaches on predicting the functional targets of two related but divergent CELF (CUGBP, 
ELAV-like factor) RBPs in mouse brain and muscle. We also demonstrate the potential of PRAS for wide 
adoption by applying it to the enhanced CLIP-seq (eCLIP) datasets of 37 RNA decay related RBPs in two 
 46 
human cell lines. PRAS can be utilized to investigate any RBPs with available CLIP-seq peaks. PRAS is 
freely available at http://ouyanglab.jax.org/pras/. 
 The oncogenic c-MYC (MYC) transcription factor has broad effects on gene expression and cell 
behavior. We show that MYC alters the efficiency and quality of mRNA translation into functional proteins. 
Specifically, MYC drives the translation of most protein components of the electron transport chain in 
lymphoma cells, and many of these effects are independent from proliferation. Specific interactions of 
MYC-sensitive RNA-binding proteins (e.g., SRSF1/RBM42) with 5′UTR sequence motifs mediate many 
of these changes. Moreover, we observe a striking shift in translation initiation site usage. For example, in 
low-MYC conditions, lymphoma cells initiate translation of the CD19 mRNA from a site in exon 5. This 
results in the truncation of all extracellular CD19 domains and facilitates escape from CD19-directed CAR-
T cell therapy. Together, our findings reveal MYC effects on the translation of key metabolic enzymes and 
immune receptors in lymphoma cells. 
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APPENDIX A: SUPPLEMENTARY FIGURES 
 
Supplementary Figure S2.1 
  
 
(a) Pearson correlation heatmap of DNA methylomes. GV: germinal vesicle stage oocytes; in vitro_MII: 
MII oocytes matured in vitro; in vivo_MII: MII oocytes matured in vivo. The numbers attached to the 
sample names indicate biological replicates. The color from blue to red indicates the correlation 
coefficient of low to high. (b) Histograms of the numbers of 100-base-pair (bp) CpG tiles captured on 
each chromosome across developmental stages. (c) Histograms of the average methylation levels of the 
100-base-pair (bp) CpG tiles captured on each chromosome across developmental stages. 
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Supplementary Figure S2.2 
 
  
 
Box plots of methylation levels at each stage across local CpG densities. 
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Supplementary Figure S2.3 
 
  
 
(a) The non-CpG methylation levels across each stage of bovine gametes and early embryos. The averaged 
non-CpG DNA methylation level of each developmental stage is calculated based on the overlapped 100-
base-pair (bp) tiles detected in all of the developmental stages analyzed. (b) The averaged non-CpG DNA 
methylation levels along the gene bodies and 15 kilobases (kb) upstream of the transcription start sites 
(TSS) and 15 kb downstream of the transcription end site (TES) of all reference genes. (c) Scatter plots of 
non-CpG DNA methylation levels of gene body regions and the relative expression levels of 
corresponding genes. The log2 of the gene expression levels (FPKM) was calculated and is presented. The 
red and blue curves in each plot represent gene expression levels and non-CpG DNA methylation levels in 
gene body regions, respectively. 
 60 
Supplementary Figure S2.4 
  
 
DNA methylation changes of DMRs of bovine gametes during preimplantation development. (a and b) 
Histogrm plots of DNA methylation levels for hypermethylated and hypomethylated 100-bp tiles in 
sperm and in vitro matured oocytes across early embryonic development stages. (c and d) Histogram 
plots of DNA methylation levels for hypermethylated and hypomethylated 100-bp tiles in sperm and GV 
oocytes across early embryonic development stages. (e) Heatmap of the methylation level of sperm-
specific DMRs between sperm and GV oocytes among different genomic regions across different 
developmental stages. (f) Heatmap of the methylation level of in vivo MII oocyte-specific DMRs 
between sperm and GV oocytes among different genomic regions across different developmental stages. 
(g) Box plots of DNA methylation levels of sperm-specific DMRs between sperm and in vitro matured 
oocytes across early embryonic development stages. (h) Box plots of DNA methylation levels of in vivo 
derived MII oocyte-specific DMRs between sperm and in vitro matured oocytes across early embryonic 
development stages. (i) Box plots of DNA methylation levels of sperm-specific DMRs between sperm 
and GV oocytes across early embryonic development stages. (j) Box plots of DNA methylation levels of 
in vitro matured oocyte-specific DMRs in comparisons between sperm and in vitro matured oocytes 
across early embryonic development stages. (k) Heatmap of the methylation level of sperm-specific 
DMRs in comparisons between sperm and in vitro matured oocytes among different genomic regions 
across different developmental stages. (l) Heatmap of the methylation level of in vitro MII oocyte-
specific DMRs in comparisons between sperm and in vitro matured oocytes among different genomic 
regions across different developmental stages. In each of these panels, the color keys from green to red 
indicate methylation levels from low to high. 
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Supplementary Figure S2.5 
  
 
(a) Dynamics of DNA methylation of LINEs (L1, L2, and BovB) during bovine embryo development. 
(b) Expression patterns of LINEs (L1, L2, and BovB) during bovine embryo development. 
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Supplementary Figure S3.1 
 
  
 
CELF4 binding characteristics in 3’UTRs. Shown are distributions of the distances between the iCLIP 
reads and the proximal/distal end of 3’UTRs in mRNAs. X-axis represents the distance (number of 
nucleotide) to the proximal/distal end of 3’UTRs. Y-axis represents the average iCLIP read counts 
within the significant peaks at that position across all the genes. The curve for the distal end is 
highlighted by red color and that for the proximal end is highlighted by blue. 
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Supplementary Figure S3.2 
 
  
 
Correlation coefficient curve and AUC curve of PRAS with different d0s. (A) The line chart of 
Pearson’s correlation coefficient between the gene score and the gene expression LFC in the qPCR-
validated targets of CELF4. The X-axis represents the different d0s applied to PRAS and the Y-axis 
shows the value of Pearson’s correlation coefficient. Each dot in the plot is for one d0 usage in PRAS. 
(B) Similar to A, but for the AUC values of the ROC analysis. These two line-charts show that the 
performance of PRAS is stable with the reasonable d0 selection around 1,000 nt. 
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Supplementary Figure S3.3 
  
 
Correlation analysis of PRAS with different reference sites. (A) The line chart of Spearman’s correlation 
coefficient between the gene score and the gene expression LFC in the Celf4-regulated list. The X-axis 
represents the different cutoffs applied to extract the subset of genes and the Y-axis shows the value of 
Spearman’s correlation coefficient. The corresponding curves for distal PRAS and proximal PRAS are 
indicated by red and blue lines, respectively. Each dot in the plot is for one subset of genes selected based 
on the absolute LFC cutoff. (B) Similar to A, but for the Celf1-regulated list. These two line-charts show 
that the top ranked targets by distal PRAS have higher enrichment in the regulated lists comparing to those 
of proximal PRAS. 
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Supplementary Figure S3.4 
 
  
 
Correlation analysis of PRAS with different peak intensity input. The line chart of Spearman’s correlation 
coefficient between the gene score and the gene expression LFC in the Celf4-regulated list. The X-axis 
represents the different cutoffs applied to extract the subset of genes and the Y-axis shows the value of 
Spearman’s correlation coefficient. The corresponding curves for PRAS-raw and PRAS-norm are 
indicated by red and blue lines, respectively. Each dot in the plot is for one subset of genes selected based 
on the absolute LFC cutoff. 
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Supplementary Figure S3.5 
 
  
 
RBP examples of eCLIP signal distribution around different reference sites. (A) Shown are distributions of 
the distances between the HNRNPU eCLIP peaks and the transcription start site (TSS) in the mRNAs of 
the HepG2 cell line. X-axis represents the distance (number of nucleotide) to the TSS. Y-axis represents 
the average eCLIP enrichment ratio within the significant peaks at that position across all the genes. (B) 
Similar to A, but around the translation initiation site (TIS) for RBP ILF3 in K562 cell line. (C) Similar to 
A, but around the translation termination site (TTS) for RBP DDX6 in HepG2 cell line. (D) Similar to A, 
but around the transcription end site (TES) for RBP LARP4 in K562 cell line. 
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Supplementary Figure S3.6 
 
  
 
Distribution of the estimated decay parameter for PRAS. Shown are the distributions of the estimated d0 
for PRAS in K562 and HepG2 cell lines. The density curves are highlighted by red and blue for RBPs in 
K562 and HepG2, respectively. The estimation is done based on the eCLIP peak intensities around the 
selected reference sites as described in the subsection “PRAS score is a strong predictor of PCR-
validated mRNA targets of CELF4”. 
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Supplementary Figure S4.1 
 
  
 
(a–c) Read count correlation plots of replicates from untreated and doxycycline (0.1 µg/ml)- treated 
ribosome footprinting and total RNA samples. (d) Frequency distribution of the ratio of TE in 
untreated (MYC ON) and doxycycline-treated (MYC OFF) P493-6 cells (TEMYC+/TEMYC−). TE 
up (red) indicates mRNAs that require MYC for translation; TE down (blue) are MYC independent. 
Biological replicates MYC ON: n = 2; MYC OFF: n = 3. 
 
a b
d
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Supplementary Figure S4.2 
  
 
MYC affects TIS choice. (a) Ribosome footprint read count correlation plots for indicated samples. (b) 
Schematic showing P-site offset for ribosome footprint reads relative to the TIS. (c) P-site offset 
measured for varying read length from 27 to 33 mer in ribosome footprinting samples. (d and e) 
Histogram of number of TISs per transcript in harringtonine-treated MYC ON (n = 3) and OFF (n = 3) 
samples. (f) ORFs detected specifically in MYC ON (n = 3) and OFF (n = 3) samples based on TIS 
detection in harringtonine-treated samples. (g) Metagene analysis of ribosome density per triplet across 
the 5’UTR of transcripts that show >50 reads per CDS in MYC ON (n = 3) and OFF (n = 3) samples 
treated with harringtonine. (h and i) Distribution of AUG codons and nearcognate NTG codons at 
predicted TISs in all ORFs and specific ORFs detected in MYC ON (n = 3) and OFF (n = 3) samples; 
significance by Fisher’s exact test. (j) uORF-containing genes are associated with increased or 
unchanged, and not with decreased, TE. 
Figure S4. MYC affects TIS choice. (a) Ribosome footprint read count correlation plots for indicated samples. (b) Schematic showing P-site offset for ri-
bo ome footprint reads relative to the TIS. (c) P-sit offset measured for varying read le g h fr m 27 to 33 mer in ribosome ootprinting samples. (d and e)
Histogram of number of TISs per transcript in harringtonine-treated MYC ON (n = 3) and OFF (n = 3) samples. (f) ORFs detected specifically in MYC ON (n = 3)
and OFF (n = 3) samples based on TIS detection in harringtonine-treated samples. (g) Metagene analysis of ribosome density per triplet across the 59UTR of
transcripts that show >50 reads per CDS in MYC ON (n = 3) and OFF (n = 3) samples treated with harringtonine. (h and i) Distribution of AUG codons and near-
cognate NTG codons at predicted TISs in all ORFs and specific ORFs detected in MYC ON (n = 3) and OFF (n = 3) samples; significance by Fisher’s exact
test. (j) uORF-containing genes are associated with increased or unchanged, and not with decreased, TE.
Singh et al. Journal of Experimental Medicine S5
c-MYC regulates mRNA translation landscape https://doi.org/10.1084/jem.20181726
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Supplementary Figure S4.3 
 
  
 
Low MYC expression favors downstream start sites that lead to functional N-terminal truncations. (a) 
Distance of ATIS detected from the annotated TIS for truncated ORFs in MYC ON (n = 3) and OFF (n 
= 3) samples. (b) Distribution of AUG codons and near-cognate NTG codons at predicted TISs for 
truncated ORFs in MYC ON (n = 3) and OFF (n = 3) samples; significance by Fisher’s exact test. (c) RF 
peak height ratios of TISs at the ATIS versus the annotated TIS indicates relative usage of aberrant and 
annotated TIS for truncated ORFs in MYC OFF (n = 3) samples. 
 
Figure S5. Low MYC expression favors downstream start sites that lead to functional N-terminal truncations. (a) Distance of ATIS detected from the
annotated TIS for truncated ORFs in MYC ON (n = 3) and OFF (n = 3) samples. (b) Distribution of AUG codons and near-cognate NTG codons at predicted TISs
for truncated ORFs in MYC ON (n = 3) and OFF (n = 3) samples; significance by Fisher’s exact test. (c) RF peak height ratios of TISs at the ATIS versus the
annotated TIS indicates relative usage of aberrant and annotated TIS for truncated ORFs in MYC OFF (n = 3) samples. (d and e) Percentage of CD19-positive
cells in MYC ON and OFF P493-6 cells (d) and control and shMYC EB1 cells (e). n = 3 biological replicates in each group. Representative data are shown from
three independent experiments. P values were calculated using an unpaired Student’s t test: **, P ≤ 0.001. (f and g) CD19–CAR-T cells (CART) and P493-6 cells
showing staining for CD3-FITC, CD20-PE/Cy5, and Annexin V (Alexa Fluor 647). n = 3 biological replicates in each group. Representative data are shown from
three independent experiments. (h) CD3-FITC and CD20-PE/Cy5 staining to differentiate the P493-6 and CD19 directed CAR-T cells population in a co-culture
experiment. (i) EB1 control cells showing staining for CD3-FITC, CD20-PE/Cy5, and Annexin V (Alexa Fluor 647). (j) CD3-FITC and CD20-PE/Cy5 staining to
differentiate the EB1 and CD19-directed CAR-T cells population in a co-culture experiment. CD20-positive cells were gated (h and j) to further analyze the
CD20+/Annexin V+ population shown in Fig. 6, j–m. n = 3 biological replicates in each group. Representative data are shown from three independent
experiments.
Singh et al. Journal of Experimental Medicine S6
c-MYC regulates mRNA translation landscape https://doi.org/10.1084/jem.20181726
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APPENDIX B: SUPPLEMENTARY TABLES 
 
Supplementary Table S1.1. Sequencing qualities, read mapping, the average covered CpG sites at 1X, 5X, 
and 10X and the bisulfite conversion rate at each stage of bovine embryo development 
Stages No. of 
Total 
Sequencin
g Reads 
No. of 
Mappable 
Reads 
Mapping 
Ratio 
Total 
Unique 
CpG 
Sites(1X) 
across 
stage 
Total 
Unique 
CpG 
Sites(5X
) across 
stage 
Total 
Unique 
CpG 
Sites(10X
) across 
stage 
Bisulfite 
Conversion 
Rate 
Sperm_1 42,995,93
9  
8,171,800  19.05% 9,925,201  5,269,26
4  
3,444,269  99.64% 
Sperm_2 44,304,01
5  
8,430,731  19.00% 99.64% 
Sperm_3 44,790,33
4  
8,644,057  19.30% 99.50% 
GV 
oocyte_1 
27,548,45
7  
7,609,130  27.55% 3,329,486  2,427,04
3  
2,149,315  99.64% 
GV 
oocyte_2 
62,635,56
9  
22,494,13
1  
36.00% 99.66% 
GV 
oocyte_3 
26,145,25
3  
8,483,532  32.45% 99.62% 
In 
vitro_Matur
e oocyte_1 
69,330,72
2  
31,984,61
3  
46.20% 1,852,930  1,269,66
0  
1,166,280  99.64% 
In 
vitro_Matur
e oocyte_2 
77,437,82
0  
39,289,82
3  
50.70% 99.66% 
In 
vitro_Matur
e oocyte_3 
21,010,32
6  
14,453,74
4  
32.35% 99.62% 
In 
vivo_Matur
e oocyte_1 
32,778,75
1  
8,572,014  26.15% 3,974,950  2,806,31
6  
2,100,123  99.60% 
In 
vivo_Matur
e oocyte_2 
* 
25,802,89
1  
657,022  2.55% 99.63% 
In 
vivo_Matur
e oocyte_3 
31,893,88
7  
10,942,54
4  
34.35% 99.68% 
2cell_1 53,818,71
1  
19,307,39
5  
35.85% 4,990,351  3,827,20
3  
3,370,405  99.62% 
2cell_2 49,443,72
7  
16,596,96
1  
33.55% 99.59% 
2cell_3 60,438,33
9  
20,453,06
9  
33.85% 99.59% 
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4cell_1 52,114,76
2  
17,562,78
6  
33.65% 3,351,058  2,608,78
4  
2,362,163  99.61% 
4cell_2 60,319,69
9  
16,742,03
8  
27.75% 99.62% 
4cell_3 * 46,662,87
6  
1,353,162  2.90% 99.26% 
8cell_3 71,991,74
8  
19,325,32
5  
26.85% 11,621,580  6,872,74
8  
4,883,138  99.61% 
8cell_2 42,391,00
7  
11,489,87
4  
27.05% 99.56% 
8cell_1 37,571,40
6  
10,288,61
7  
27.60% 99.53% 
Early 
Morula_1 
66,234,70
8  
23,780,96
6  
35.95% 4,879,048  3,194,84
2  
2,506,589  99.60% 
Early 
Morula_2 
57,351,37
0  
29,954,86
6  
52.25% 99.54% 
Early 
Morula_3 
34,227,42
6  
10,301,68
5  
30.25% 99.66% 
Compact 
Morula_1 
22,604,32
1  
7,124,383  31.80% 3,065,791  2,271,43
5  
1,905,354  99.65% 
Compact 
Morula_2 
28,728,03
8  
8,241,313  28.80% 99.60% 
Compact 
Morula_3 
32,199,79
5  
13,910,72
1  
43.45% 99.65% 
Blastocyst_
1 
35,132,03
1  
8,543,949  24.60% 5,810,378  3,527,67
7  
2,510,965  99.69% 
Blastocyst_
2 
38,343,17
4  
10,486,86
0  
27.45% 99.50% 
Blastocyst_
3 * 
23,502,23
6  
14,044  0.10% 99.62% 
* sample removed for downstream analysis. 
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Supplementary Table S1.2. List of top 20 genes that promoter methylation was significantly and inversely 
correlated with gene expression at the 8-cell stage. 
gene meth log2(8cell_FPKM) 
RPL32 0.004385963 12.49091855 
RPS3 0.006448877 13.22399414 
RPL37 0.009624113 11.99353639 
HMGN2 0.005339773 9.503799904 
RPLP1 0.01110277 11.18097828 
RPS17 0.011714179 11.62215709 
IMP3 0.005382453 8.787687118 
NDUFB1 0.004937026 8.713455254 
KPNA2 0.005543985 8.785423042 
TPT1 0.012550528 11.97897495 
UQCRFS1 0.010416674 9.354668133 
RPS28 0.012918541 11.68779557 
AURKA 0 8.057628973 
RPL36AL 0.01083076 8.905573535 
SKP1 0.010741267 8.634622308 
PPIA 0.013904638 11.81528722 
UQCRB 0.007638385 7.937544491 
RAB1A 0.005740744 7.759828278 
OAZ1 0.013148499 9.809655602 
NDUFB8 0.013184748 9.86500014 
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Supplementary Table S1.3. The hypergeometric enrichment analysis of the hypermethylated and 
hypomethylated tiles in bovine gametes, exhibited the strong enrichment for different genomic regions 
(hypergometric enrichment test). 
Genomi
c 
regions 
Sperm vs. In vivo MII (P 
value) 
Sperm vs. In vitro MII (P 
value) 
Sperm vs. GV (P value) 
Hypermethyl
ated 
Hypomethyl
ated 
Hypermethyl
ated 
Hypomethyl
ated 
Hypermethyl
ated 
Hypomethyl
ated 
Exons 1.90E-125 1.00E-147 3.50E-55 6.90E-37 1.20E-34 1.50E-80 
Introns 2.30E-182 1 1.40E-58 1 6.90E-48 1 
Promot
ers 
1 0 1 0 1 0 
LINE 0.0037 1 0.014 1 0.12 1 
SINE 0.00055 1 0.12 1 0.11 1 
LTR 1 1 1 1 1 1 
CGI 1 0 1 0 1 0 
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Supplementary Table S1.4. Methylation levels of DMRs in in vitro_MII and in vivo_MII oocytes. Only 
tiles that are highly methylated in in vivo_MII oocytes are shown. 
Tile In 
vivo_MII 
In 
vitro_MII 
Genomic 
region 
Gene body 
chr24_27695 50.0% 49.6% NA NA 
chr29_493730 100.0% 97.8% NA NA 
chr7_166679 100.0% 83.6% exon SMARCA4 
chr4_53396 100.0% 79.7% intron DDC 
chr22_611969 100.0% 71.2% NA NA 
chr28_265967 50.0% 33.3% SINE PPA1 
chr28_436501 100.0% 65.9% intron WDFY4 
chr25_358525 50.0% 28.9% SINE COL26A1 
chr4_1146632 50.0% 20.4% LINE NA 
chr13_774167 100.0% 33.3% NA NA 
chr21_597250 100.0% 33.3% NA NA 
chrUn_GJ057830v1_1 100.0% 14.5% NA NA 
chr1_52674 50.0% 7.1% NA NA 
chrUn_GJ058425v1_1437 100.0% 4.8% NA NA 
chr1_101969 100.0% 0.0% LINE NA 
chr1_671281 100.0% 0.0% LINE NA 
chr12_129879 100.0% 0.0% NA NA 
chr15_849050 100.0% 0.0% NA NA 
chr16_580319 100.0% 0.0% LINE TNR 
chr16_784219 50.0% 0.0% NA NA 
chr19_360207 100.0% 0.0% NA NA 
chr19_580299 50.0% 0.0% NA NA 
chr20_697797 100.0% 0.0% NA NA 
chr20_72106 100.0% 0.0% LINE NA 
chr22_109572 100.0% 0.0% intron ITGA9 
chr25_329553 100.0% 0.0% SINE NA 
chr26_452533 100.0% 0.0% NA NA 
chr5_1192280 50.0% 0.0% NA NA 
chr7_1054652 100.0% 0.0% SINE NA 
chr9_876387 100.0% 0.0% LINE NA 
chrX_12476 50.0% 0.0% NA NA 
chrX_544118 100.0% 0.0% NA NA 
chrX_566496 50.0% 0.0% LINE NA 
chrX_725651 100.0% 0.0% LTR NA 
 
